Document technical information

Format pdf
Size 324.0 kB
First found Jun 9, 2017

Document content analysis

not defined
no text concepts found





Initial treatment: NNRTI + 2 NRTIs or PI + 2 NRTIs
o MOA: interfere with HIV viral RNA-dependent DNA polymerase, resulting in chain termination &
inhibition of viral replication
o Class toxicities:
Lactic acidosis, sever hepatomegaly with steatosis
Most require renal dosing (except abacavir)
o Do not use lamivudine & emtricitabine together (chemically similar)
o Do not use zidovudine with stavudine together (both require thymidine for activation)
o Do not use didanosine with stavudine during pregnancy (increased risk of lactic acidosis & liver damage)
o The “D” drugs cause pancreatitis & peripheral neuropathy & lactic acidosis
ddI (didanosine), d4T (stavudine), ddC (zalcitabine)
o Low pill burden
o All are prodrugs requiring 2-3 phosphorylations for activation
o Zidovudine (Retrovir):
SE: bone marrow suppression, GI intolerance
Dosage forms available: IV, 200 mg (10 mg/mL); syrup 50 mg/5 mL in 240 mL; capsule, 100
mg & tablet 300 mg
o Lamivudine (Epivir):
Minimal toxicity
o Abacavir (Ziagen):
SE: hypersensitivity reaction that can be fatal with rechallenge
o Didanosine (Videx, Videx EC):
Take ½ hour before or 2 hours after meals (empty stomach)
SE: pancreatitis, peripheral neuropathy
o Stavudine (Zerit):
SE: pancreatitis, peripheral neuropathy
o Zalcitabine (Hivid):
SE: pancreatitis, peripheral neuropathy
o Tenofovir (Viread):
SE: renal insufficiency
o Emtricitabine (Emtriva):
Minimal toxicity
o Combination products:
Zidovudine 300 mg + lamivudine 150 mg (Combivir)
Zidovudine 300 mg + lamivudine 150 mg + abacavir 300 mg (Trizivir)
Tenofovir 300 mg + emtricitabine 200 mg (Truvada)
Lamivudine 300 mg + abacavir 600 mg (Epzicom)
o MOA: bind to reverse transcriptase at a different site than the NRTIs, resulting in inhibition of HIV
o Class toxicities: rash & hepatoxicity
o All should be dosed for hepatic impairment
o Most are affected by food (except efavirenz)
o Efavirenz is CI in pregnancy
Page 1
Efavirenz (Sustiva):
Take on an empty stomach
SE: CNS side effect; false + cannabinoid test
Nevirapine (Viramune):
SE: rash, symptomatic hepatitis, including fatal hepatic necrosis
Delavirdine (Rescriptor):
SE: rash, increased LFTs
MOA: inhibit protease, which then prevents the cleavage of HIV polyproteins & subsequently induces
the formation of immature noninfectious viral particles
All should be dosed for hepatic impairment
Most should be taken with food (except amprenavir & indinavir)
Amprenavir & fosamprenavir are chemically similar- avoid combination
Atazanavir & indinavir require normal acid levels in stomach for absorption
Ritonavir is the most potent
Lopinavir/ritonavir, ritonavir, & saquinavir gel caps require refrigeration
Class toxicities: lipodystrophy, hyperglycemia, hyperlipidemia, hypertriglyceridemia, bleeding in
hemophiliace, osteonecrosis & avascular neocrosis of the hips, osteopenia & osteoporosis
All are CYP3A4 inhibitors
Lopinavir + ritonavir (Kaletra):
SE: GI intolerance
Refrigerate caps stable until date on label; stable for 2 months at room temperature
Atazanavir (Reyataz):
SE: increased indirect hyperbilirubinemia, prolonged PR interval
Fosamprenavir (Lexiva):
SE: rash
Oral solution contains propylene glycol
Amprenavir (Agenerase):
SE: rash
Avoid high fat meal
SQV-hard gel cap (HGC)- (Invirase):
• SE: GI intolerance
• Room temperature
SQV- soft gel cap (SGC)- (Fortovase):
• SE: GI intolerance
• Refrigerated caps stable until date on label; stable for 3 months at room temperature
HGC & SGC are not bioequivalent & should not be interchanged
Nelfinavir (Viracept):
SE: diarrhea
Needs 500 kCal of food for absorption; take after eating
Ritonavir (Norvir)
SE: GI intolerance
Refrigerated caps stable for 1 month at room temp
Page 2
Indinavir (Crixivan):
SE: nephrolithiases- drink at least 48 oz. daily to prevent
Take on an empty stomach
Fusion inhibitors:
o MOA: binds to gp41 on HIV surface, which inhibits HIV binding to CD4 cell
o Enfuvirtide (Fuzeon)
Salvage regimens
Reconstituted form should be stored in the refrigerator- stable for 24 hours
Post-exposure Prophylaxis (PEP):
o Start therapy within 1-2 hours of exposure
o Length of therapy is 4 weeks
o Treatment options:
AZT 200 mg po Q8h or 300 mg po Q12h AND 3TC(lamivudine) 150 mg po Q12h
AZT 200 mg po Q8h or 300 mg po Q12 + 3TC 150 mg po Q12h + Indinavir 800 mg Q8h
• OR Nelfinvir 750 mg po Q8h or 1250 mg Q12h
PCP treatment:
o A protozoan, but may be more closely related to fungi
o Treat when CD4+ cells fall below 200
o DOC: trimethoprim-sulfamethoxazole (Bactrim DS) DS po QD
o Alternatives:
TMP + dapsone
Atovaquone (Mepron)
Pentamidine (NebuPent; Pentam-300)
• Comes as injection & powder for nebulization
Clindamycin + primaquine
Trimetrexate (NeuTrexin) + folinic acid
o Treatment for PCP also covers prophylaxis for: toxoplasmosis
CMV: Cytomegalovirus
o Ganciclovir (Cytovene, Vitrasert):
Use: treatment of CMV retinitis in immunocompromised individuals, including patients with
CI: ANC <500/mm3 or PLT <25,000/mm3
Dosage forms:
• Capsule (Cytovene)
• Implant, intravitreal (Vitrasert)- 4.5 mg released gradually over 5-8 months
• Injection, powder for reconstitution
Alzheimer’s Disease:
Donepezil (Aricept):
o Cholinesterase inhibitor
o MOA: reversibly & noncompetitively inhibits centrally active acetylcholinesterase, the enzyme
responsible for hydrolysis of acetylcholine
o Available dosage forms: tablets, ODT
o Max dose: 10 mg QD
Galantamine (Razadyne, Razadyne ER, Reminyl-old name):
o Acetylcholinesterase inhibitor
o Max dose:
IR tablet or solution: 24 mg/day (in 2 divided doses)
ER capsule: 24 mg/day
Memantine (Namenda):
o Low affinity, non-competitive, voltage dependent NMDA receptor antagonist
o Neuroprotective
o Less cognitive decline & improves cognition in impaired patients
Page 3
o After depolarization, Namenda leaves the site & allows sodium & calcium entry into the cell
o Behaves like magnesium
o Approved for moderate to severe Alzheimer’s Disease
Rivastigmine (Exelon):
o Acetylcholinesterase inhibitor (central)
o MOA: increases acetylcholine in the CNS through reversible inhibition of its hydrolysis by
o SE: GI upset
o Dosage forms: capsules & solution
Folic acid deficiency would also be called: macrocytic anemia, pernicious anemia
Macrocytic (large cell):
o Megaloblastic:
Vitamin B12 deficiency
• Lack of intrinsic factor results in pernicious anemia
Folic acid deficiency
Hct, Hgb, RBC, MCH
Normochromic, normocytic:
o Aplastic anemia
o Anemia of chronic disease
Hypochromic (low hemoglobin content), microcytic (small cell):
o Iron deficiency
o Genetic anomalies: Sickle cell anemia, thalassemia
o Darbepoetin Alpha (Aranesp):
Recombinant human erythropoietin
Caution in patients with HTN or with a hx of seizures
• Can cause hypo- or hypertension
Available as an injection
o Epoetin Alpha (Epogen):
Colony stimulating factor
Onset of action: several days
Peak effect: 2-3 weeks
SQ 1-3X per week
Acetaminophen overdose:
o Antidote: Acetylcysteine (Mucomyst, Acetadote):
MOA: thought to reverse APAP toxicity by providing substrate for conjugation with the toxic
Dose: oral- 140 mg/Kg followed by 17 doses of 70 mg/Kg Q4h; repeat dose if emesis occurs
within 1 hour of administration
Albuterol overdose:
o Antidote: propranolol or beta blocker
Anticholinergic overdose:
o Antidote: Physostigmine (Antilirium):
Do not use if solution is cloudy or dark brown
Arsenic overdose:
o Antidote: Succimer (Chemet) or dimercaprol (British anti-lewisite, BAL in oil)
Benzodiazepine overdose:
o Antidote: flumazenil (Romazicon)
-blocker overdose:
Page 4
o Antidote: glucagon (GlucaGen)
CCB overdose:
o Antidote: calcium chloride 10% or glucagon (GlucaGen)
Carbamates overdose:
o Antidote: atropine
Coumadin overdose:
o Antidote: Vitamin K1 or phytonadione (Mephyton, AquaMEPHYTON); fresh frozen plasma
Digoxin overdose:
o Antidote: digoxin immune antibody fragment (Digibind, DigiFab)
Iron overdose:
o Antidote: deferoxamine (Desferal)
Isoniazid overdose:
o Antidote: pyridoxine (Vitamin B6)
Lead overdose:
o Antidotes:
Succimer (Chemet)
Dimercaprol; also called British anti-lewisite (only for lead encephalopathy)
Calcium disodium EDTA (calcium disodium versenate)
o Antidote for folic acid antagonists (methotrexate, trimethoprim, pyrimethamine)
o Water soluble vitamin
Magnesium overdose:
o Death due to muscle relaxation (includes heart failure)
o Antidote: calcium
Methanol or Ethylene glycol overdose:
o Antidote: Ethanol 10%
o Antidote: Fomepizole (Antizol)
AKA: 4-methylpyrazole or 4-MP
MOA: competitively inhibits alcohol dehydrogenase, an enzyme which catalyzes the metabolism
of ethanol, ethylene glycol, & methanol to their toxic metabolites
?Decreases metabolism of methanol
Methemoglobinemia overdose:
o Antidote: methylene blue
Opioid overdose:
o Antidote: Naloxone (Narcan)
MOA: opioid antagonist that competes at all three CNS opioid receptors (mu, kappa, & delta)
o Antidote: Nalmefene (Revex)
Organophosphates overdose:
o Antidote: atropine or pralidoxime (Protopam)
Salicylate overdose:
o Antidote: sodium bicarbonate
TCAs overdose:
o Antidote: sodium bicarbonate
Type Ia antiarrhythmics overdose:
o Antidote: sodium bicarbonate
Drugs available for nebulization:
o Budesonide 0.25 & 0.5 mg (Respules®)
o Cromolyn (Intal®)
Mast cell stabilizer
Use: adjunct in the prophylaxis of allergic disorders, including asthma; prevention of exerciseinduced bronchospasm
• Nasal: for prevention & treatment of seasonal & perennial allergic rhinitis
o Albuterol
Page 5
o Ipratropium
o Ipratropium & Albuterol
Drugs available as MDI:
o Beclomethasone HFA 40 mcg/puff & 80 mcg/puff (QVAR®)
o Flunisolide 250 mcg/puff (Aerobid®)
o Fluticasone 44, 110, 220 mcg/puff (Flovent®)
o Cromolyn (Intal®)
o Nedocromil (Tilade®)
o Albuterol (Proventil®, Ventolin®)
o Pirbuterol (Maxair Autohaler®)
o Ipratropium (Atrovent®)
o Ipratropium & Albuterol (Combivent®)
Drugs available as turbuhaler:
o Budesonide 200 mcg/inhalation (Pulmicort®)
Drugs available for dry powder inhalation (DPI):
o Fluticasone (Flovent Rotadisk®)
o Fluticasone-salmeterol (Advair Diskus®)
o Formoterol (Foradil Aerolizer®)
o Salmeterol (Servent Diskus®)
Stable for 6 weeks after removing foil
1 inhalation BID
Drugs available as MDI/spacer:
o Triamcinolone 100 mcg/puff (Azmacort®)
Class of drugs to use to prevent a child allergic to pollen from having an asthma attack- could use antihistamines,
cromolyn or inhaled corticosteroids
A patient would monitor their asthma from home with a peak flow meter which measures the FEV1
o Goal: 80% of personal best
Montelukast (Singulair):
o MOA: selective leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor
o Dosing;
6-23 months: 4 mg oral granules
2-5 years: 4 mg chewable tablet or oral granules
6-14 years: 5 mg chewable tablet
>15 years: 10 mg tablet
Take in evening
o Granules must be used within 15 minutes of opening
Zafirlukast (Accolate):
o MOA: selectively & competitive leukotriene-receptor antagonist of leukotriene D4 & E4
o Use: prophylaxis & chronic treatment of asthma in adults & children >5 years old
o Dose: 20 mg BID
o Administer 1 hour before or 2 hours after meals
o Monitor: LFTs
o Extensively hepatically metabolized via CYP2C9
o 0.80 AT = T
o SE:
15-25 mcg/ML: GI upset, N/V/D, nervousness, headache, insomnia, agitation, dizziness, muscle
cramp, tremor
25-35 mcg/mL: tachycardia, occasional PVC
> 35 mcg/mL: ventricular tachycardia, frequent PVC, seizure
o Theophylline + erythromycin increased levels of theophylline
A patient who has had too much albuterol could be given a cardioselective beta blocker
Ebola: virus; no cure
Page 6
Anthrax: bacteria (aerobic, gram + bacillus); ciprofloxacin or doxycycline for 60 days
Tamulosin (Flomax) & Alfuzosin (Uroxatrac):
o Greater affinity to -1 in prostate
o Less SE
o Work quickly for instant relief
Finasteride (Proscar/Propecia) & Dutasteride (Avodart):
o Great for a large prostate
o Take longer to work
Doxazosin (Cardura) & terazosin (Hytrin) also used for BPH
Saw palmetto
Chemo drugs that should be refrigerated: cyclophosphamide (after reconstitution)
o Pyrimidine analogs: interfere with the synthesis of pyrimidine bases & thus DNA synthesis
Can cause mucositis
Capecitabine (Xeloda)
Fluorouracil; 5-FU (Adrucil)
Cytarabine (Cytosar)
Gemcitabine (Gemzar)
o Folic acid analog: interferes with synthesis of pyrimidine bases & thus DNA synthesis
• After reconstitution with preservative: may refrigerate
o Purine analogs: interfere with synthesis of purine bases & thus DNA synthesis
Mercaptopurine (Purinethol)
• DI with allopurinol
Thioguanine (Tabloid)
Fludarabine (Fludara)
Cladribine (Leustatin)
Pentostatin (Nipent)
Plant alkaloids:
o Vinca alkaloids: bind to tubulin to prevent formation of microtubules during mitosis
Fatal if administered intrathecally
Vincristine (Oncovin):
• Neurotoxic
Vinblastine (Velban)
Vinorelbine (Navelbine)
o Podophyllotoxins: bind to tubulin, inhibiting topoisomerase II to cause DNA strand breaks
Etoposide; VP-16 (VePesid)
Teniposide (Vumon)
o Taxanes: bind to tubulin, promotes synthesis of nonfunctional microtubules
Paclitaxel (Taxol)
• Use a in-line filter; non-PVC
Docetaxel (Taxotere)
o Camptothecins: inhibits topoisomerase I, stabilizing single-strand breaks in DNA
Irinotecan (Camptosar)- *Diarrhea*
Topotecan (Hycamtin)
Alkylating Agents: cross-link between DNA bases or between DNA strands to inhibit DNA replication
o Nitrogen Mustard Derivative:
Mechlorethamine (Mustargen)
Melphalan (Alkeran)
Chlorambucil (Leukeran)
Ifosfamide (Ifex)
Page 7
Carmustine (BiCNU)
Lomustine (CeeNU)
Stretozocin (Zanosar)
Thiotepa (Thiopex)
Busulfan (Myleran)
Dacarbazine (DTIC)
Antitumor antibiotics:
o Anthracycline:
Cardiotoxic: 450-550 mg/m2 cumulative lifetime dose
Doxorubicin (Adriamycin):
• MOA: appears to directly bind to DNA & inhibit DNA repair (via topoisomerase II
inhibition) resulting in the blockade of DNA & RNA synthesis & fragmentation of DNA
• Turns urine & all other body fluids red
• SE: myelosupression, cardiotoxicity, extravasation
• Decrease dose in renal impairment
Daunorubicin (Cerubidine)
Idarubicin (Idamycin)
Mitoxantrone (Novaantrone)
o Other:
Mitomycin C (Mutamycin)
Bleomycin (Blenoxane)
Heavy Metals:
o Cisplatin (Platinol)
o Carboplatin (Paraplatin)
o Oxaliplatin (Eloxatin)
Antiandrogens: inhibit uptake & binding of testosterone & dihydrotestosterone in prostatic tissue
o Flutamide (Eulexin)
o Bicalutamide (Casodex)
o Nilutamide (Nilandron)
Progestins: suppress release of LH & increase estrogen metabolism (decrease available estrogen for estrogendependent tumors)
o Megestrol (Megase): also used to stimulate appetite
o Medroxyprogesterone (Provera)
Estrogens: estramustine is combination of estrogen plus nitrogen mustard; estrogen facilitates uptake, nitrogen
mustard released to alkylate cancer cells
o Estramustine (Emcyt)
Antiestrogens: bind to estrogen receptor in breast tissue, preventing binding by estrogen & thereby reducing
estrogen-stimulated tumor growth
o Tamoxifen (Nolvadex)
o Toremifine (Fareston)
Gonadotropin-releasing hormone analogs: turn off negative-feedback release of FSH & LH, reducing
testosterone & estrogen production in testes & ovaries
o Leuprolide (Lupron (breast/prostate); Eligard (prostate); Viadur (prostate))
o Goserelin (Zoladex)
Aromatase inhibitors: blocks enzyme responsible for conversion of circulating androgens to estrogens
o Anastrazole (Arimidex):
For breast cancer
Can increase LDL
Cannot use with Tamoxifen
AE: vasodilation, headache, pain, depression, hot flashes, HTN, osteoporosis
o Letrozole (Femara)
Other miscellaneous agents for cancer:
o Asparaginase (Elspar)
o Hydroxyurea (Hydrea)
Page 8
Tyrosine kinase inhibitors:
Imatinib mesylate (Gleevec)
Erlotinib (Tarceva)
Gefitinib (Iressa)
o 26S Proteasome inhibitor:
Bortezomib (Velcade)
o Biological Response Modifiers
Immune therapies:
• Aldesleukin (Proleukin)
• Interferon-alpha 2b (Intron A)
• Levamisole (Ergamisol)
o Monoclonal antibodies:
Rituximab (Rituxan)
Trastuzumab (Herceptin): works at HER-1 receptor
Gemtuzumab (Mylotarg)
Alemtuzumab (Campath)
Bevacizumab (Avastin)
Cetuximab (Erbitux)
Denileukin diftitox (Ontak)
Ibritumomab tiuxetan (Zevalin)
Tositumomab (Bexxar)
Mesna is given with cyclophosphamide & ifosfamide to prevent hemorrhagic cycstitis
Colony Stimulating Factors:
o Filgastrim (Neupogen):
MOA: granulocyte colony stimulating factor (G-CSF); stimulation of granulocyte production in
patients with malignancies
Increases production of neutrophils
Does not cause agraulocytosis—used to treat it
SE: bone pain
Store in refrigerator
o Pegfilgrastim (Neulasta):
MOA: stimulates the production, maturation, & activation of neutrophils; activates neutrophils to
increase both their migration & cytotoxicity
Prolonged duration of effect relative to filgastrim & reduced renal clearance
Store in refrigerator
SE: bone pain
Octreotide (Sandostatin):
o Somatostatin analog
o Use: antidarrheal agent for diarrhea secondary to cancer
o MOA: mimics natural somatostatin by inhibiting serotonin release, & the secretion of gastrin, VIP,
insulin, glucagons, secretin, motilin & pancreatic polypeptide
o Dosage forms available: injection only
High emetic potential:
o Cisplatin, cyclophosphamide, cytarabine, dacarbazine, ifosfamide, melphalan, mitomycin,
Prevention of Acute Chemotherapy-Induced N/V:
o 5-HT3 receptor antagonist:
Dolasetron (Anzemet)
Granisetron (Kytril)
Ondansetron (Zofran)
Palonosetron (Aloxi)
o Phenothiazines:
Prochlorperazine (Compazine)
Page 9
Chlorpromazine (Thorazine)
Promethazine (Phenergan)
Droperidol (Inapsine)
Haloperidol (Haldol)
Dexamethasone (Decadron)
Dronabinol (Marinol)
Lorazepam (Ativan)
Metoclopramide (Reglan)
Neurokinin-1 Antagonist:
Aprepitant (Emend):
• Substance P/neurokinin 1 receptor antagonist
• Uses: prevention of acute & delayed N/V associated with highly-emetogenic
chemotherapy in combination with a corticosteroid (i.e. dexamethasone) & 5-HT3
(ondansetron) receptor antagonist
• Avoid with grapefruit juice (CYP3A4)
• MOA: prevents acute & delayed vomiting by selectively inhibiting the substance
P/neurokinin 1 (NK1) receptor
• Dose: oral: 125 mg on day 1, followed by 80 mg on days 2 & 3
o 1st dose should be given 1 hour prior to chemotherapy
o Benazepril (Lotensin)
o Captopril (Capoten):
Used to decrease the progression of CHF
SE: rash, hyperkalemia, angioedema, cough
• Tablets: 12.5, 25, 50, & 100 mg
o Enalapril (Vasotec):
Enalaprilat (Vasotec): only ACEI available as IV
• 1.25 mg/dose given over 5 minutes Q6 hours
40 mg/day max dose
o Fosinopril (Monopril)
o Lisinopril (Prinvil, Zestril)
o Moexipril (Univasc)
o Perindopril (Aceon)
o Quinapril (Accupril)
o Ramipril (Altace)
o Trandolapril (Mavik)
o Proven to decrease mortality in CHF
o Ineffective as monotherapy in African Americans
o MOA: inhibit the conversion of angiotensin I to angiotensin II (a potent vasoconstrictor)
o SE: increased SCr, cough, angioedema, sexual dysfunction, hyperkalemia, rash
o CI: bilateral renal artery stenosis; pregnancy
Alpha agonists:
o MOA: causes decreased sympathetic outflow to the cardiovascular system by agonistic activity on central
-2 receptors
o Clonidine (Catapres)
More withdrawal
Unlabeled use: heroin or nicotine withdrawal
Page 10
Guanabenz (Wytensin)
Guanfacine (Tenex)
Less withdrawal
o Methyldopa (Aldomet)
o SE: sedation, dry mouth, bradycardia, withdrawal HTN, orthostatic hypotension, depression, impotence,
sleep disturbances
Alpha blockers:
o MOA: blocks peripheral -1 postsynaptic receptors, which causes vasodilation of both arteries & veins
(indirect vasodilators)
o Causes less reflex tachycardia than direct vasodilators (hydralazine/minoxidil)
o Dosazosin (Cardura)
o Prazosin (Minipress)
o Terazosin (Hytrin)
o Counseling: take 1st dose at bedtime, may cause dizziness
o SE: weight gain, peripheral edema, dry mouth, urinary urgency, constipation, priapism, postural
No effects on glucose or cholesterol
Anti-arrhythmic Drugs:
o Arrhythmias:
A. Fib or flutter: DOC- digitalis glycoside; alternative- verapamil or propranolol
Supraventricular tachycardia: DOC- verapamil or adenosine; alternative- diltiazam or
Ventricular premature complexes: DOC- beta blocker; alternative- beta blocker
Ventricular tachycardia: DOC- beta blocker; alternative- amiodarone
Ventricular fibrillation: DOC- amiodarone; alternative- beta blocker
Digoxin-induced tachyarrhythmia: DOC- lidocaine; alternative- phenytoin
Torsades de pointes: DOC- magnesium; alternative- beta blocker
Class IA: inhibit fast Na channels
• Quinidine
o SE: Cinchonism
• Procainamide (Pronestyl)
o SE: lupus-like syndrome
• Disopyramide (Norpace)
Class IB: inhibit fast Na channels
• Lidocaine (Xylocaine):
• Phenytoin (Dilantin)
o SE: nystagmus
• Tocainide (Tonocard)
• Mexiletine (Mexitil)
Class IC: inhibit fast Na channels
• Moricizine (Ethmozine)
• Flecainide (Tambocor)
• Propafenone (Rhythmol)
Class II: beta-adrenergic agents
• Propranolol (Inderal)
• Esmolol (Brevibloc)
• Acebutolol (Sectral)
Class III: primarily block K channels
• Bretylium (Bretylol)
• Amiodarone (Cordarone®):
o SE:
IV: phlebitis
General: corneal microdeposits, photophobia, LFTs, photosensitivity,
blue-gray skin discoloration, pulmonary fibrosis (reduced at low doseso
Page 11
300 mg/d; increases as dose increases), hyper- or hypothyroidism,
o Watch for iodine allergy
o Avoid grapefruit juice
o Prior to use: check thyroid levels, eye exam
• Ibutilide (Corvert)
• Sotalol (Betapace)
• Dofetilide (Tikosyn)
o SE: torsades de pointes
Class IV: calcium channel antagonists
• Verapamil (Isoptin, Calan)
o Direct thrombin inhibitors:
• A synthetic molecule that reversibly binds to thrombin
• Eliminated by the liver
• Use if renal impairment
Lepirudin (Refludan):
• Recombinant DNA-derived polypeptide nearly identical to hirudin
• Produces an anticoagulant effect by binding directly to thrombin & does not require AT
to produce it effect
• Does not bind to other proteins as heparin does
• Eliminated by the kidneys
• Use if liver impairment
o Enoxaparin (Lovenox):
Low molecular weight heparin
MOA: inhibits factor Xa greater than IIa
• DVT prophylaxis: 40 mg QD or 30 mg BID
• DVT treatment: 1 mg/Kg/dose Q12 hours or 1.5 mg/Kg/dose QD
Monitor: anti-Xa, platelets
o Heparin:
MOA: potentiates the action of antithrombin III & prevents the conversion of fibrinogen to fibrin
• DVT prophylaxis: 5000 units SQ Q8-12 hours
• IV infusion: 10-30 units/Kg/hr
• Line flushing: 10 units/mL for infants (<10 Kg); 100 units/mL for older infants, children
& adults
Monitor: PTT (1.5-2X the upper limit of control; 50-70 sec), platelets
o Warfarin (Coumadin, Jantoven)
MOA: inhibits reduction of vitamin K to its active form; leads to depletion of vitamin Kdependent clotting factors II, Vii, IX, X & protein C & S
Requires 4-5 days before full anticoagulation effect is achieved
Recommended starting dose: 5 mg po QD
Strengths/Dosage forms:
• Injection: 5 mg
• Tablets: 1, 2, 2.5, 3, 4, 5, 6, 7.5, 10 mg
Most indications want an INR in the 2.0-3.0 range
• Mechanical valves require a higher level of anticoagulation (INR 2.5-3.5)
Minor bleeding or elevated INR: hold warfarin dose or decrease dose until INR returns to
appropriate range
Purple Toe Syndrome may occur due to cholesterol microembolization
o Acetaminophen is usually a good antipyretic & analgesic choice for patients taking oral anticoagulants
Page 12
Risk factors for DVTs: >40 years old; prolonged immobility; major surgery involving the abdomen,
pelvis, & lower extremities; trauma, especially fractures of the hips, pelvis, & lower extremities;
malignancy; pregnancy; previous venous thromboembolism; CHF or cardiomyopathy; stroke. Acute MI;
indwelling central venous catheter; hypercoagulability; estrogen therapy; varicose veins; obesity; IBD;
nephrotic syndrome; myeloproliferative disease; smoking
Antiplatelet Drugs:
o Thienopyridines:
MOA: block adenosine diphosphate (ADP)-mediated activation of platelets by selectively &
irreversibly blocking ADP activation of the glycoprotein IIb/IIIa complex
Clopidogrel (Plavix):
• Use: reduce atherosclerotic events (MI, stroke, vascular deaths)
• MOA: blocks the ADP receptors, which prevents fibrinogen binding at that site &
thereby reducing the possibility of platelet adhesion & aggregation
• AE: chest pain, headache, dizziness, abdominal pain, vomiting, diarrhea, arthralgia, back
pain, upper respiratory infections
Ticlopidine (Ticlid):
• Maintenance dose: 250 mg BID
• DC if the ANC drops to <1200 or platelet count drops to <80,000
• AE: rash, nausea, dyspepsia, diarrhea, neutropenia, thrombotic thrombocytopenic
• Dosage form: 250 mg tablet
CI: active bleed, severe liver disease, ticlopidine: neutropenia, thrombocytopenia
o Glycoprotein IIb/IIIa inhibitors:
Abciximab (Reopro)
• No renal dosing adjustment required
Eptifibatide (Integrillin)
Tirofiban (Aggrastat)
• Storage: room temperature, protect from light
o Candesartan (Atacand)
o Eprosartan (Tevetan)
o Irbesartan (Avapro)
o Losartan (Cozaar)
o Olmesartan (Benicar)
o Telmisartan (Micardis)
o Valsartan (Diovan)
Beta Blockers:
o Nonselective:
Nadolol (Corgard)
Penbutolol (Levatol)
• Has ISA
Pindolol (Visken)
• Has ISA
Propranolol (Inderal):
• Nonselective beta blocker
• Can increase cholesterol
• Strengths available:
o ER capsule (InnoPran XL): 80, 120 mg
o SR capsule (Inderal LA): 60, 80, 120, 160 mg
o Injection (Inderal): 1 mg/mL
o Solution: 4 mg/mL; 8 mg/mL
o Tablet (Inderal): 10, 20, 40, 60, 80 mg
Timolol (Blockadren)
o Cardioselective:
Page 13
Acebutolol (Sectral)
• Has intrinsic sympathomimetic activity (ISA)
Betaxolol (Kerlone)
Bisoprolol (Zebeta)
Metoprolol (Lopressor, Toprol XL)
• Strength/dosage forms:
o Lopressor:
Injection: 1 mg/mL
Tablet: 25, 50, or 100 mg
ER tablets: 50 & 100 mg
o Toprol XL:
Tablets: 25, 50, 100, 200 mg
Labetalol (Trandate):
• Beta blocker (heart rate drop) with alpha-blocking (vasodilation & BP drop) activity
Carvedilol (Coreg):
• MOA: blocks -1, -2, & -1 receptors
• Has had proven effects on patient survival in large clinical trials for HF
• Take with food
• Antioxidant effects
• Preferred in HF patients who BP is poorly controlled due to its greater hypertensive effect
• Increases stroke volume
MOA: competitively blocks response to beta-adrenergic stimulation:
Blocked secretion of renin; decrease cardiac contractility, thereby decreasing CO; decreased
central sympathetic output; decreased HR, thereby decreasing CO
o MOA: inhibit the influx of Ca ions through slow channels in vascular smooth muscle & cause relaxation
of both coronary & peripheral arteries
SA & AV nodal depression & decrease in myocardial contractility (nondihydropyridines)
o Nondihydropyridines:
o SE: conduction defects, worsening of systolic dysfunction, gingival hyperplasia
Diltiazem (Cardizem, LA & CD, Dilacor XR, Tiaziac)
• SE: nausea, headache
• Cardizem: 30, 60, 90, 120 mg tablets
• Cardizem LA: 120, 180, 240, 300, 360, 420 mg
• Cardizem CD: 120, 180, 240, 300, 360 mg capsules
• IR: (Calan, Isoptin)
• LA: (Calan SR, Isoptin SR)
• Coer: (Covera HS, Verlan PM)
• SE: constipation
o Dihydropyridines:
SE: edema of the ankle, flushing, headache, gingival hyperplasia
Amlodipine (Norvasc)
Felodipine (Plendil)
Isradipine (DynaCirc & CR)
Nicardipine (Cardene SR)
Nifedipine (Procardia XL, Adalat CC)
Nisoldipine (Sular)
Combination products:
o Amlodipine & benazepril (Lotrel)
o Losartan & HCTZ (Hyzaar)
Direct vasodilators:
o SE: headaches, fluid retention, tachycardia, peripheral neuropathy, postural hypotension
Page 14
Hydralazine (Apresoline)
Minoxidil (Loniten)
o Monitor: urine output, edema, weight
o Loops:
MOA: reduction of total fluid volume through the inhibition of Na & Cl reabsorption in the
ascending loop of Henle, which causes increased excretion of water, Na, Cl, Mg, & Ca
Are more effective that thiazides in patients with renal failure (SCr >2 mg/dL or GFR < 30
AE: ototoxicity at high doses; photosensitity; may increase blood glucose in diabetics; orthostatic
hypotension; hypokalemia; gout
DI: aminoglycosides (increase risk of ototoxicity), NSAIDs (blunt diuretic response), Class Ia or
III antiarrhythmics (may cause torsades de pointes with diuretic induced hypokalemic);
probenecid (blocks loop effects by interfering with excretion into the urine)
Bumetanide (Bumex)
Furosemide (Lasix)
• Available dosage forms: injection, solution, tablet
Torsemide (Demadex)
o Thiazides:
MOA: direct arteriole dilation; reduction of total fluid volume through the inhibition of Na
reabsorption in the distal tubules, which causes increased excretion of Na, water, K, & hydrogen;
increase the effectiveness of other antihypertensive agents by preventing re-expansion of plasma
Significant decrease in efficacy in renal failure (SCr > 2 mg/dL or GFR < 30 mL/min)
DI: steroids (cause salt retention & antagonize thiazide action), NSAIDs (blunt thiazide
response), Class Ia or III antiarrhythmics (may cause torsades de pointes with diuretic induced
hypokalemic); probenecid & lithium(blocks thiazide effects by interfering with excretion into the
urine), lithium (thiazides decrease lithium renal clearance & increase risk of lithium toxicity)
AE: increased cholesterol & glucose (short term); decreased: K, Na, Mg; increased: uric acid &
Ca; photosensitivity; pancreatitis; impotence; sulfonamide-type reactions
Bendroflumethiazide (Naturetin)
Benzthiazide (Aquatag, Exna)
Chlorothiazide (Diuril)
Chlorthalidone (Hygroton, Hylidone)
Hydrochlorothiazide (HydroDIURIL, Microzide)
Hydroglumethiazide (Saluron, Diucardin)
Polythiazide (Renese)
Trichlormethiazide (Metahydrin, Naqua)
o Thiazide-like:
Less or no hypercholesterolemia compared to other thiazides; decreased microalbuminuria in DM
Metolazone (Mykrox, Zaroxolyn)
Indapamide (Lozol)
o Potassium-sparing:
MOA: interferes with K/Na exchange in the distal tubule; decreases Ca excretion, increases Mg
AE: hyperkalemia
Amiloride (Midamor)
Triamterene (Dyrenium)
• Avoid with history of kidney stones or hepatic disease
o Aldosterone Blocker:
Eplerenone (Inspra):
• Selective
• CI: DM type II; K > 5.5; ClCr < 30 mL/min
Page 15
• PO- tablet 25 & 50 mg
• K sparing
Spironolactone (Aldactone)
Epinephrine (Adrenalin):
o MOA: stimulates -, -1, & -2 adrenergic receptors resulting in relaxation of smooth muscle of the
bronchial tree, cardiac stimulation, & dilation of skeletal muscle vasculature
o Sensitive to light & air- protection is recommended
Oxidation turns drug pink, then a brown color
Solutions should not be used if they are discolored or contain a precipitate
Admixture is stable at room temperature for 24 hours
Heart failure:
o Drugs that can worsen or precipitate:
Antiarrhythmics: disopyramide, flecainide, propafenone
Beta blockers
CCB: verapamil & diltiazem
Oral antifugals: itraconazole & terbinafine
Cardiotoxic drugs: doxorubicin, daunorubicin, cyclophosphamide, alcohol
Na & water retention: NSAIDs, glucocorticoids, rosiglitazone, pioglitazone
o Metoprolol, bisoprolol, & carvedilol have all shown to be effective in HF
o Digoxin (Lanoxin):
Does not improve mortality, but does produce symptomatic benefits
MOA: inhibits Na-K-ATPase pump, which results in an increase in intracellular Ca, which
causes a + inotropic effect
• Reduces sympathetic outflow from the CNS
AE: arrhythmias, bradycardia, heart block, anorexia, abdominal pain, N/V, visual disturbances,
confusion, fatigue
• Toxicity is more commonly associated with serum concentrations > 2 ng/mL, but may
occur at lower levels if patients have hypokalemia, hypomagnesemia, & in the elderly
Serum levels: 0.5-1.0 ng/mL
60-80% is eliminated renally- dosage requirement for renal insufficiency
o ACEI & beta blockers improve mortality
o Aldosterone antagonist reduce the risk of death & hospitalization
o Diuretics- symptomatic relief
o Dobutamine (Dobutrex):
MOA: stimulates -1 receptors causing increased contractility & heart rate, with little effect on
-2 or alpha receptors
-1 > -2 >
• Increases CO & vasodilates
Use: inotropic support for patients with shock & hypotension
Dosage: start at 3 mcg/Kg/min & titrate to 20 mcg/Kg/min
o Dopamine (Intropin):
MOA: depends on the given dose
• 1-5 mcg/Kg/min: renal dose; increases urine output
o Stimulates dopamine receptors
• 5-15 mcg/Kg/min: increases contractility, HR
o Stimulates -1 & -2 receptors
• >15 mcg/Kg/min: increases BP
o Stimulates -1 receptors
Extravasation: give phentolamine
o Milrinone (Primacor):
MOA: inhibits phosphodiesterase III, increases cAMP, resulting in positive inotropic &
vasodilating effects
Use: short-term IV therapy of CHF; calcium antagonist intoxification
Dosage: 50 mcg/kg LD over 10 min; followed by 0.375 mg/Kg/min
Page 16
Preferred over amrinone because of decreased risk of thrombocytopenia
MONA-B for MI:
o Morphine, oxygen, NTG, Aspirin, beta blockers
Norepinephrine (Levophed):
o MOA: stimulates -1 adrenergic receptors & -adrenergic receptors causing increased contractility & HR
as well as vasoconstriction thereby increasing systemic BP & coronary blood flow
Alpha effects > beta effects
o Readily oxidized, protect from light
o Do not use if brown coloration
o Admixture stable at room temperature for 24 hours
Postganglionic adrenergic neuron blockers:
o Guanadrel (Hylorel)
o Guanethidine (Ismelin)
o Reserpine (Serpasil)
Can cause depression
Torsades de pointes:
o Common drugs that can cause it:
quinidine, dofetilide (Tikosyn), sotalol (Betapace), thioridazine, ziprasidone (Geodon)
o Use:
ST-elevation > 1 mm in 2 or more contiguous leads or left bundle branch block
Presentation within 12 hours or less of symptoms onset
In patients >75 years old may be useful & appropriate
Can be used in STEMI when time to therapy is 12-24 hours if chest pain is ongoing
Should NOT be used if the time to therapy is >24 hours, & the pain is resolved
CI in a patient with NSTEMI
o Drugs:
Streptokinase (SK, Streptase)
Tissue plasminogen activator (tPA, Alteplase)
Tenecteplase (TNK, TNKase)
o Nitroprusside (Nitropress):
Use: hypertensive crises; CHF
Watch for cyanide toxicity (especially with hepatic dysfunction)
Watch for thiocyanate toxicity (especially with renal dysfunction or prolonged infusions)
Highly sensitive to light
• Normally a brownish color
• A blue color indicates almost complete degradation & breakdown to cyanide
o Nesirtide (Natrecor):
B-type natriuretic peptide that increases diuresis & is an arterial & venous dilator
o Nitroglycerin (NitroBid, Nitrostat):
Venous dilator but also an arterial dilator at higher doses
Drugs that must be mixed with sterile water:
o Amphotericin B: no electrolytes, mix in D5W, & reconstitute with sterile water
1 lb = 454 gm
1 in = 2.54 cm
1 grain = 64.8 mg
1 avoirdupois pound = 454 gm
1 fluid ounce = 29.57 mL
Page 17
1 gallon = 128 fluid ounces
o Also 3785 mL, 4 quarts, 8 pints
1 pint = 473 mL (round to 480 mL)
1st line therapy: beta-2 agonist or ipatropium
Counseling Points:
Calcitonin (Miacalcin):
o For injection:
Keep vials in refrigerator
Stable for 2 weeks at room temperature
Give injection in upper arm, thigh or buttock
o Nasal spray:
Store unopened bottle in refrigerator
Once pump has been activated, store at room temperature
• Good for 30 days
Must prime prior to first use or if it has been greater than 5 days
o Adequate vitamin D & calcium intake is essential for osteoporosis
o May cause increased warmth & flushing (should last only about 1 hour after administration)
Take in evening to minimize discomfort
Sulfa eye drops: burns
Nicotine gum: chew until peppery taste appears, then park
Cystic Fibrosis:
Autosomal recessive disease of exocrine gland function resulting in abnormal mucus production
Genetic mutation on the long arm of chromosome 7
o The protein encoded by this gene, the cystic fibrosis transmembrane regulator (CFTR), is a channel
involved in the transport of water & electrolytes
o Most common genetic mutation involves a 3-base-pair deletion at position F508
Antibiotics for Cystic Fibrosis:
o Cover for Staphylococcus aureus, H. flu, & pseudomonas
Double coverage of antibiotics when pseudomonas (most common) is suspected
• Antipseudomonal PCN: piperacillin (Pipracil), mezlocillin (Mezlin), piperacillintazobactam (Zosyn), ticarcillin-clavulanate (Timentin), ticarcillin (Ticar), aztreonam
(Azactam), meropenem (Merrem), or imipenem (Primaxin)
• Or a cephalosporin: ceftazidime (Fortaz, Tazidime, Tazicef)
• AND an aminoglycoside: tobramycin
Vancomycin for MRSA
Burkholderia & Stenotrophomonas species are commonly resistant
• Trimethoprim-sulfamethoxazole (Bactrim), chloramphenicol (Chloromycetin),
ceftazidime, doxycycline, piperacillin
o Fluoroquinolones are the ONLY oral antibiotics with good coverage against pseudomonas
Pulmozyme (dornase alfa):
o Recombinant human deoxyribonuclease
o Use: for management of CF patient to reduce the frequency of respiratory infections that require
parenteral antibiotics, & to improve pulmonary function
o MOA: reduces mucous viscosity resulting in airflow improvement
o Used with a nebulizer (jet nebulizer)
o Must be stored in the refrigerator & should be protected from light
Should not be exposed to room temp for a total of 24 hours
Should not be mixed with or diluted with other drugs in the nebulizer
Swan Ganz catheter:
Page 18
o Inserted into right side of heart into the pulmonary circulation
o Measures pulmonary capillary wedge pressure
o Takes accurate measurement of BP
You must measure the scrotum to fit a swimmer’s athletic support
o Armpits should be 2 inches away from crutches
o Rapid-acting:
Lispro (Humalog)
Aspart (NovoLog)
Glulisine (Apidra)
Onset: <15 min
Peak: 30-90 min
Duration: 3-5 hours
o Short-acting:
Regular- human (Humulin R, Novolin, Velosulin BR)
Regular- purified (Regular Ilentin II-pork)
Onset: 30-60 min
Peak: 2-3 hours
Duration: 3-6 hours
o Intermediate-acting:
NPH- isophane insulin suspension (NPH Iletin II- pork)
Human (Humulin N, Novolin N)
Lente- insulin zinc suspension (Lente Iletin II- pork)
Human (Humulin L, Novolin L)
Onset: 2-4 hours
Peak: 6-12 hours
Duration: 10-18 hours
o Long-acting:
Ultralente- extended insulin zinc suspension; human (Humulin U, Ultralente)
• Onset: 6-10 hours
• Peak: 10-16 hours
• Duration: 18-20 hours
Insulin glargine (Lantus)
• Onset: 5 hours
• Peak: none
• Duration; 20-24 hours
• Cannot mix with any other insulin
o Premixed products:
50/50: 50% regular with 50% NPH
• Rapid acting for pre-meal & intermediate acting to control later hyperglycemia
70/30: 30% regular with 70% NPH
70/30 analogue: 30% aspart with 70% neutral protamine aspart insulin analogue
75/25: 25% lispro with 75% neutral protamine lispro insulin analogue
o MOA: decreases blood glucose & assists with glucose control by:
Increasing glucose uptake & utilization by peripheral tissues (primarily in muscle)
Increasing glycogenesis (glucose glycogen; primarily in liver)
Decreasing glycogenolysis (glycogen glucose)
Decreasing gluconeogenesis (amino acids glucose)
Decreasing lipolysis & ketogenesis (fats ketone bodies)
Converting amino acids to increase protein
Converting triglycerides & fatty acids to increase adipose tissue
o Appearance:
Page 19
Clear (solution): aspart, lispro, glulisine, glargine, regular
Cloudy (suspension): NPH, lente, ultralente, all premixed insulin products
o Sites of injection: abdomen > arm > hip > thigh > buttock
In order of greater & more rapid absorption to lesser & slower absorption
o There’s 1000 units in a 10 mL bottle
Insulin secretagogues:
o MOA: stimulates pancreatic cells to secrete insulin
o 1st generation sulfonylureas: can cause a disulfiram-like rxn
Acetohexamide (Dymelor)
Chlorpropamide (Diabinese)
Tolazamide (Tolinase)
Tolbutamide (Orinase)
o 2nd generation sulfonylureas
Glimepiride (Amaryl)
• Max dose: 8 mg/day
Glipizide (Glucotrol, Glucotrol XL)- use in renal impairment
Glyburide (Diabeta, Micronase)- safe in pregnancy
Glyburide micronized (Glynase)
o Regular meal times are necessary- must not skip
o SE: hypoglycemia & weight gain
Alpha-glucosidase Inhibitors:
o Acarbose (Precose)
o Miglitol (Glyset)
Least likely to cause hypoglycemia even when fasting
o Should be taken with the first bite of a meal
o MOA: delays carbohydrate metabolism & absorption (due to competitive & reversible inhibition of
intestinal alpha-glucoside hydrolase & pancreatic alpha-amylase)
o SE: GI intolerance
o To treat a hypoglycemic attack: treat with oral glucose
Sucrose or fructose would not work
o Metformin (Glucophage, Fortamet, Riomet):
MOA: insulin resistance
• 1° in liver; 2° in periphery
Dosage: start with 500 mg po BID or 875 mg po QD
• Max: ~2500 mg QD (850 mg TID)
When to hold: in patients undergoing diagnostic radiology procedures that use an iodinated
contrast media; hold for 48 hours after the radiology drug is administered
• i.e. angiogram
SE: GI, megaloblastic anemia, & lactic acidosis (Scr men <1,5, women <1.4- don’t use)
Thiazoladinediones (glitazones or TZDs):
o Pioglitazone (Actos)
o Rosiglitazone (Avandia): need AST prior to starting
Wait 3 months before deciding on therapeutic failure
o MOA: insulin resistance
1° in periphery; 2° in liver
o SE: edema, anemia, weight gain, exacerbation of CHF, URIs, resumption of ovulation
Meglitinides (nonsulfonylurea secretagogues):
o Repaglinide (Prandin)
Max daily dose: 16 mg/day
o Nateglinide (Starlix)
o MOA: stimulates pancreatic cells to secrete insulin
o SE: hypoglycemia, weight gain, GI
Combination drugs:
o Glyburide + Metformin (Glucovance)
Page 20
o Glipizide + Metformin (Metaglip)
o Rosiglitazone + Metformin (Avandamet)
Example of question: Diabeta is most like Prandin
Glyset will not cause hypoglycemia
o Only sulfonylureas & insulin will lower blood sugar in non-diabetics
Glucagon (GlucaGen):
o Use: management of hypoglycemia
Unlabeled use: beta blocker & CCB overdose
o MOA: stimulates adenylate cyclase to produce increased cAMP, which promotes hepatic glycogenolysis
& gluconeogenesis, causing a rise in blood glucose levels
o 1 unit = 1 mg
Diabetic nephropathy:
o Microalbuminuria (30-300 mg albumin/24 hours) used to diagnosis
o Annual screening for DM type II measures microalbumin-creatinine ratio (normal <30)
Diabetic neuropathy:
o Treat with TCA’s
o Neurontin, carbazepine
o ACEI treat the decreased renal function, NOT the neuropathy itself
o A potentially fatal complication that occurs in up to 5% of patients with Type I annually
o Seen less frequently in Type II
o Precipitating factors: interruption of insulin therapy, sepsis, trauma, MI, pregnancy
o Clinical features: N/V, vaguely localized abdominal pain; dehydration, respiratory distress, shock &
coma can occur
o Lab evulation: anion gap metabolic acidosis & positive serum ketones; plasma glucose is usually
Hyponatremia, hyperkalemia, azotemia, & hyperosmolality
o Treatment:
Supportive measures
Insulin therapy
Dextrose (5%)- once plasma glucose decreases to 250 mg/dL & the insulin infusion rate
decreased to 0.05 U/Kg/hr
Bicarbonate therapy
Phosphate & magnesium
Drug-Drug Interactions:
Sertraline (Zoloft) & diltiazem (Cardizem; Cartia XT; Dilacor XR; Diltia XT; Taztia XT; Tiazac)
o Carbamazepine (Tegretol):
Na channel blocker
An autoinducer
Tegretol XL: ghost tablets in stool
SE: rash (rarely causing DC), folate deficiency, hepatotoxicity, aplastic anemia
Cannot be given for status epilepticus
o Felbamate (Felbatol):
Rarely used
MOA: blocks glycine on N-Methyl-D-Aspartate receptor (NMDA)
SE: hepatotoxicity, aplastic anemia
50% renal elimination
o Gabapentin (Neurontin):
Page 21
MOA: unknown; structurally related to GABA but does not interact with GABA receptors
Also used for peripheral neuropathies
100% renal elimination- no DI that effect drug metabolism
Al or Mg containing antacids may decrease absorption
Lamotrigine (Lamictal):
MOA: decrease glutamate & aspartate release, delays repetitive firing of neurons, blocks Na
SE: life-threatening skin rash
• Titrate slowly to avoid
Levetiracetam (Keppra):
MOA: may prevent hypersynchronization of epileptiform burst firing & propagation of seizure
Adjust in renal dysfunction
Oxycarbazepine (Trileptal):
MOA: Na channel blocker
PKS: active metabolite- 10-monohydroxycarbazepine (MHD)
SE: hyponaturemia; blood dysrasias
Phenobarbital (Barbital, Luminal, Solfoton):
MOA: increases GABA-mediated Cl- influx
SE: drowsiness, dizziness, hyperactivity, folate deficiency, hepatic failure, SJS
Decreases effectiveness of BC pills
Phenytoin (Dilantin):
MOA: Na channel blocker
Can only prepare in NS @ 50 mg/mL
Highly protein bound
SE: peripheral neuropathy, hydantoin faces, acne, hirsutism, gingival hyperplasia, osteomalacia,
vitamin K- deficient hemorrhagic disease, folate deficiency, hepatic failure, SJS
DC tube feedings 2 hours before & after a dose of phenytoin
Available dosage forms: suspension, chewable tablet, prompt-release capsule, ER capsule,
Need albumin level to calculate phenytoin level
Primidone (Mysoline):
MOA: increase GABA-mediated Cl- influx
Metabolized to Phenobarbital & phenylethylmalonamide (PEMA)
Primidone, Phenobarbital, & PEMA all have anti-epileptic activity
Tiagabine (Gabitril):
MOA: blocks GABA reuptake in presynaptic neuron
Topiramate (Topamax):
MOA: blocks Na channels, enhances GABA activity, antagonizes AMPA/kainite activity
• Also a weak carbonic anhydrase inhibitor
Elimination: primarily renal
SE: drowsiness, dizziness, kidney stones, oligohidrosis (may not sweat)
Sprinkle capsules can be opened & sprinkled onto a small amount of cool, soft food (i.e.
applesauce or yogurt)
Drink plenty of fluids
Valproic acid:
MOA: blocks T-type Ca currents, blocks Na channels, increases GABA production
SE: weight gain, alopecia, thrombocytopenia, increased LFTs, heptotoxicity (fatal), hemorrhagic
pancreatitis (fatal), folic acid deficiency
Available dosage forms:
• Sodium valproate (Depacon): injection
• Divalproex sodium:
o Depakene: syrup & gel capsule
Page 22
o Depakote Sprinkles: capsules
o Depakote: delayed-release tablets
o Depakote ER: ER tablet
o Zonisamide (Zonegran):
MOA: Na channel blocker, blocks T-type Ca channels (currents)
• Weak carbonic anhydrase inhibitor
SE: kidney stones, weight loss, oligiohidrosis
Sulfa drug
Nonpharmacologic therapy:
o Ketogenic diet: devised in the 1920’s
High in fat & low in carbohydrates & protein
Leads to acidosis & ketosis
Most calories are provided in the form of cream & butter
No sugar allowed
Fluids are also controlled
Status epilepticus: seizure lasting longer than 5 minutes or 2 discrete seizures between which there is
incomplete recovery of consciousness
o Treatment:
ABC’s: airway, breathing, circulation
1st line: benzodiazepines
• Lorazepam (Ativan): rapid onset
• Diazepam (Valium)
IV phenytoin (Dilantin)
• provided patient was not on phenytoin at home
• Can only mix with NS
• 15-20 mg/Kg
• Contains propylene glycol- cardiotoxic therefore do not infuse faster than 50 mg/min
• Fosphenytoin (Cerebyx):
o Prodrug of phenytoin
o Improves water solubility of phenytoin
o Can be admixed with any IV solution
o Dosed in PE (phenytoin equivalents): 1 mg of phenytoin = 1.5 mg of
o Can be give at a rate of 150 mg/min
IV Phenobarbital (20 mg/Kg)or begin a continuous infusion of midazolam
Begin a medically-induced coma
• Must be on a vent
BMI: body mass index
o Men = 66 + (13.7 X W) + (5 X H) – (6.8 X A)
o Women = 665 + (9.6 X W) + (1.8 X H) – (4.7 X A)
o Where W= adjusted body weight in Kg; H= height in centimeters; A= age in years
o 1 in = 2.54 cm
CrCl = (140- age) (IBW)
X 0.85 (if woman)
(72) (SCr)
IBWman= 50 + 2.3 (inches over 5’)
IBWwoman= 45.5 + 2.3 (inches over 5’)
ABW = IBW + 0.4 (Actual – ideal)
Henderson Hasselbach:
o pH= pka + log [base]/[acid]
o log values:
log 100 = 2
log 10 = 1
log 1 = 0
Page 23
log 0.1 = -1
log 0.001 = -2
T1/2 = 0.693 VD/Cl
Fanconi’s Syndrome:
A congenital anemia due to low production of RBC’s
Can also be induced by anything that causes failure of the proximal renal tubules
Patients develop polyuria (cannot concentrate the urine), osteomalacia, & reduced growth size
At one time it was associated with the use of out-dated tetracycline but this is no longer a problem since the
product has been reformulated
o The filler was the actual culprit
Cimetidine (Tagamet)
Famotidine (Pepcid)
Nizatidine (Axid)
Ranitidine (Zantac)
MOA: suppresses gastric acid secretion by inhibiting the parietal cell H+/K+ ATP pump
Rabeprazole (AcipHex):
Strength/dosage form: delayed-release EC 20 mg tablet
o Esomeprazole (Nexium):
Strength/dosage form:
• Capsule: delayed release 20 & 40 mg
• Injection, powder for reconstitution: 20 & 40 mg
o Lansoprazole (Prevacid):
Strength/dosage form:
• Capsule: delayed release 15 & 30 mg
• Granules, for oral suspension: 15 & 30 mg/packet
• Injection, powder for reconstitution: 30 mg
• ODT: 15 & 30 mg
o Omeprazole (Prilosec):
Do not put in OJ- not stable in an acidic environment
Cannot sprinkle onto food
Strength/dosage form:
• Capsule: delayed release 10 & 20 mg
• Oral suspension (Zegerid): 20 & 40 mg
• Tablet: delayed release 20 mg (OTC)
o Pantoprazole (Protonix):
Strength/dosage form:
• Injection, powder for reconstitution: 40 mg
• Tablet: delayed release 20 & 40 mg
o Take 15-30 minutes before breakfast to maximize efficacy
GERD can exacerbate asthma
Increased intraocular pressure, which causes pathologic changes in the optic nerve & typical visual field defects
Open-angle glaucoma:
o Primary glaucoma
o The angle of the anterior chamber remains open in an eye, but filtration of aqueous humor is gradually
diminished because of the tissues of the angle
o 80-90% of cases
Angle-closure (narrow angle) glaucoma:
o Primary glaucoma
Page 24
Shallow anterior chamber & narrow angle; filtration of aqueous humor is compromised as a result of the
iris blocking the angle
-adrenergic antagonists:
MOA: decrease in aqueous humor formation with slight increase in outflow (beta selective)
Often DOC for open-angle glaucoma
AE: cardiac effects, worsening pulmonary effects, depression, dizziness
• Timolol (Timoptic)
• Carteolol (Ocupress)
• Levobunolol (Betagen)
• Metipranolol (OptiPranolol)
• Betaxolol (Betoptic)
• Levobexaxolol (Betaxon)
o Carbonic anhydrase inhibitors:
MOA: decrease in aqueous humor formation
AE: lethargy, decreased appetite, GI upset, urinary frequency
Do not use with sulfa allergy
Acetazolamide (Diamox)
• Tablets, capsules
Dorzolamide (Trusopt)
Brinzolamide (Azopt)
Methazolamide (Neptazane)
• Tablets
o Prostaglandin analogs:
MOA: increased uveoscleral outflow without effect on aqueous humor formation
Also used as 1st line agents or in combination with beta blockers
AE: iris pigmentation, eyelid darkening, macular edema
Latanoprost (Xalatan)
• Administer 1 drop at bedtime
• Refrigerate
• Can change blue eyes to brown
Bimatoprost (Lumigan)
• Can cause darkening of eyelids & eye lashes
Travoprost (Travatan)
• Frequent ocular hyperemia
Unoprostone (Rescula)
-2 adrenergic agonists:
MOA: decrease in aqueous humor formation
AE: tachycardia, dry mouth, eyelid elevation, CNS effects in the old & young
Brimonidine (Alphagan)
• Wait at least 15 minutes after using before placing soft contacts
o Other -adrenergic agonists:
MOA: increase in aqueous humor outflow
AE: tachycardia, increased BP, allergic responses
Dipivefrin (Propine)
• Prodrug of epinephrine
Pilocarpine (Pilocar)
• Once weekly dose form called Ocuserts
o Combination:
Timolol & dorzolamide (Cosopt)
Page 25
Treatment of acute attack:
o Colchicine:
MOA: inhibits phagocytosis of urate crystals by leukocytes; anti-inflammatory agent without
analgesic activity
• Decrease leukocyte mobility thereby decreasing inflammation
Dosed until resolution of symptoms, severe GI symptoms occur, or max of 8 mg
Available PO (0.6 mg) & IV (0.5 mg/mL)
o Indomethacin
o Corticosteroids
Effective when given intra-articularly, IV, or PO
Used when there is failure to colchine and NSAIDS
o Colchicine (low dose: 0.6-1.2 mg/d)
o Colchicine + probenecid (ColBenemid)
o Probenecid (Benemid):
MOA: uricosuric agent that promotes the excretion of UA by blocking its reuptake at the
proximal convoluted tubule
• Inhibits renal absorption of UA from the urine into the blood
Should drink at least 2 L of water/day to decrease the risk of UA stone formation
Avoid use with aspirin
o Sulfinpyrazone (Anturane):
MOA: uricosuric agent that promotes the excretion of UA by blocking its reuptake at the
proximal convoluted tubule
Drink at least 2 L of water/day
Do not use with CrCl < 50 mL/min
o Allopurinol (Zyloprim):
MOA: allopurinol & its metabolite oxypurinol, inhibit xanthine oxides formation, which is the
rate-limiting step in UA synthesis; this facilitates the clearance of the more water soluble
precursors of UA, oxypurines
• Inhibits xanthine oxides which reduces UA formation from the metabolism of purine
bases of DNA & RNA
Take with food
Watch for rash- SJS can occur
DI: azathioprine & 6-mercaptopurine
o Soap suds enema QD
o Sitz bath QD
o Fiber therapy
o Sitting on a doughnut
o Cleaning anal area with soap & water after each defecation
o Dibucaine (Nupercainal): OTC local anesthetic for fast temporary relief of pain & itching due to
o Pramoxine (Anusol ointment, ProctoFoam NS, Tucks): OTC local anesthetic for fast temporary relief of
pain & itching due to hemorrhoids
Hepatic Encephalopathy:
Syndrome of disordered consciousness & altered neuromuscular activity seen in patients with acute or chronic
hepatocellular failure or portosystemic shunting
Precipitating factors: azotemia; use of tranquilizer, opioid, or sedative-hypnotic medication; GI hemorrhage;
hypokalemia & alkalosis; constipation; infection; high-protein diet
Monitor: ammonia levels
o Fleet’s enema
Page 26
Protein restriction; special diet (vegetable protein or branched-chain amino acid enriched)
Nonabsorbable disaccharides: lactulose (Cephulac, Constulose, Enulose, Generlac, Kristalose), lactitol,
& lactose
Lactulose syrup 30 mL of 50% solution QID; diminish to BID when 3 or more bowel movements
a day occur daily
o Uses: dyspepsia, oral mucositis, dermatitis, ADHD
o Might have anti-inflammatory effects; might bind to GABA receptors
o DI: benzodiazepines, tamoxifen, CNS depressants, warfarin, estrogens, CYP1A2 & CYP3A4 substrates
o CROSS-ALLERGENICITY: German chamomile may cause an allergic reaction in individuals sensitive
to the Asteraceae/Compositae family; members of this family include ragweed, chrysanthemums,
marigolds, daisies, and many other herbs
o Uses: PMS, BPH, menstrual irregularities, female infertility, insect repellant
o DI: antipsychotics, contraceptives, dopamine agonists, estrogens, metoclopramide
Cholesterol: garlic
o St. John’s Wort, SAM-e (& OA), DHEA, Kava-kava (anxiety, stress)
Dong quai:
o Used for PMS & menopausal symptoms
o Interaction with warfarin- made up of several coumarin constitutes
Increase INR
o Use: migraines, arthritis, allergies
o DI: anticoagulants, antiplatelets, CYP (1A2, 2C9, 2C19, 3A4)
o Use: OA, TMJ, glaucoma
o Glucosamine is an amino sugar, which is a constituent of cartilage proteoglycans. It is derived from
marine exoskeletons or produced synthetically
o DI: APAP, antidiabetic agents, warfarin
Kava Kava:
o Uses: insomnia, anxiety, stress, benzodiazepine withdrawal
o May adversely affect the liver- increase LFTs
o DI: xanax, CNS depressants CYP (1A2, 2C19, 2C9, 2D6, 2E1, 3A4), hepatotoxic drugs, levodopa
Milk thistle:
o Used for liver disorders; dyspepsia
o Interactions with CYP2C9 (warfarin, elavil, diazepam), CYP3A4 substrates, estrogens
o Avoid with hormone sensitive cancers
Hot flashes & menopausal symptoms: black cohosh
Passion Flower:
o Used for anxiety, GAD, opioid withdrawal
o Interactions with CNS depressants
o Uses: applied locally for wart removal;
o Can increase LFTs
o Uses: depression & OA
o S-adenosylmethionine (SAMe) is a naturally occurring molecule that is distributed throughout virtually
all body tissues and fluids; concentrations are highest in childhood & decrease with age
o Plays an essential role in >100 biochemical rxn involving enzymatic transmethylation
Page 27
It contributes to the synthesis, activation &/or metabolism of hormones, neurotransmitters, nucleic acids,
proteins, phospholipids, & some drugs
o DI: antidepressants, dextromethorphan, levodopa, meperidine
St. John’s Wort:
o Uses: depression, anxiety
o Two constituents that play a significant role are hypericin & hyperforin
o MOA: believed to act as a serotonergic 5-HT3 and 5-HT4 receptor antagonist, & down-regulate betaadrenergic, & serotonergic 5-HT1 & 5-HT2 receptors when used chronically in animals
o DI: triptans, xanax, elavil, antidepressants, barbiturates, plavix, OCs, cyclosporine, dextromethorphan,
CYP (1A2, 2C9, 3A4), warfarin
o Used for anxiety, stress, insomnia
o A sedative; similar effects to Ambien
o Avoid with: etoh, benzadiazepines, CNS depressants, CYP3A4 substrates
Some herbs that affect platelet aggregation: angelica, clove, danshen, dong quai, garlic, ginger, ginkgo, feverfew,
Panax ginseng, horse chestnut, red clover, turmeric
Sodium polystyrene disulfonate (Kayexalate): cation exchange resin- promotes the exchange of Na for K in GIT
o Can be administered as a retention enema
IV insulin
o Causes K to shift into the cells & temporarily lowers the plasma K
Calcium gluconate
o Decreases membrane excitability
o Administer 1st with hyperkalemia & EKG changes
Other: IV NaHCO3 (shifts K into cells); -2 adrenergic agonists (promote the cellular uptake of K); Loop &
thiazide diuretics (enhance K excretion if renal function is adequate); dialysis
If the patient also has EKG changes the usual treatment (in order) is:
o IV calcium first
o Then IV bolus of 10-20 units of regular insulin with 25 gm of glucose (prevents hypoglycemia)
o 150 mEq of sodium bicarbonate is one liter of D5W forces K into cells
o Beta-2 agonists (i.e. Albuterol) nebulized or SQ
o Combination of loop & thiazide (i.e. Lasix + Diuril) if the renal function is adequate
o Kayexalate (slow to work)
o Hemodialysis is best overall, if the time is available & K is severe
o Peritoneal dialysis is less effective
Bile Acid Sequestrants:
o Effects on cholesterol:
TG: or <-->
o Cholestyramine Resin (Questran, Prevalite):
MOA: forms a nonabsorable complex with bile acids in the intestine, releasing chloride ions in
the process; inhibits enterohepatic reuptake of intestinal bile salts & thereby increases the fecal
loss of bile salt-bound low density lipoprotein cholesterol
o Colesevelam (WelChol)
Strength/dosage forms: 625 mg tablet
o Colestipol (Colestid)
o Not absorbed; safest for pregnant women
o Effects on cholesterol:
Page 28
LDL: or <-->
MOA: increase catabolism (breakdown) of triglycerides
Can cause pancreatitis & liver problems
Fenofibrate (Tricor)
Changed from 160 mg (with meals) to 145 mg
• Made it nanocrystals for better bioavailability
Gemfibrozil (Lopid)
Take 30 minutes before breakfast & dinner
Clofibrate (Atromid-S)
o Effects on cholesterol:
o MOA: HMG-CoA reductase inhibitors
o Atorvastatin (Lipitor)
o Fluvastatin (Lescol, Lescol XL)
Shortest t1/2
o Lovastatin (Mevacor, Altoprev- with niacin)
Strengths/Dosage forms:
• Tablet: 10, 20, 40 mg
• Mevacor: 20, 40 mg ER tablets
• Altoprev: 10, 20, 40, 60 mg tablets
No grapefruit
o Pravastatin (Pravachol)
Not metabolized in the liver- therefore statin with the least amount of DIs
o Rosuvastatin (Crestor)
o Simvastatin (Zocor)
No grapefruit
o All except for Lipitor & Crestor should be administered in the evening
o Pregnancy category: X
o Monitor: LFTs, CK
Cholesterol Absorption Inhibitor:
o Effects on cholesterol:
HDL: or <-->
o Ezetimibe (Zetia):
Monitor for muscle pain & increased liver enzymes
Niacin (Niacor, Niaspan, Slo-Niacin: OTC):
o Synonyms: Nicotinic acid; vitamin B3
o Effects on cholesterol:
o MOA: inhibits the synthesis of VLDL
o Target dose: 1.5-6 g/day in 3 divided doses with or after meals
o SE: flushing (pretreat by taking aspirin 30 minutes prior), dizziness, lightheadedness
o Caution in DM & gout
Combination products:
Page 29
Niacin & lovastatin (Advicor)
Ezetimibe & simvastatin (Vytorin)
Aspirin & pravastatin (Pravigard PAC)- aspirin tablets & pravastatin tablets are separate tablets within the
Exercise will help to raise HDL
Graves disease- most common cause
Thyroid storm is a life threatening, sudden exacerbation of all the symptoms of thyrotoxicosis characterized by
fever, tachycardia, delirium, & coma
Can be caused by drugs such as amiodarone & iodine
S/Sx: heat intolerance, weight loss, weakness, palpitation, anxiety, tremor, tachycardia, eyelid sag, warm or moist
Diagnosis: T4 or T3, TSH
Three modes of treatment:
o Surgery
o Radioactive iodine (RAI)
o Antithyroid (thionamide) drugs:
Propylthiouracil (PTU):
• MOA: inhibit the synthesis of thyroid hormones by preventing the incorporation of
iodine into iodotyrosines & by inhibiting the coupling of monoiodotyrosine &
diiodotyrosine to form T4 & T3; also inhibits the peripheral conversion of T4 to T3
• Dosage form: tablets
Methimazole (Tapazole):
• MOA: inhibit the synthesis of thyroid hormones by preventing the incorporation of
iodine into iodotyrosines & by inhibiting the coupling of monoiodotyrosine &
diiodotyrosine to form T4 & T3
SE: fever, headache, paresthesias, rash, arthralgia, urticaria, jaundice, hepatitis, agranulocytosis,
leucopenia, bleeding
o Iodide drugs:
Strong iodine solution (Lugol’s Solution):
• Dosage form: solution- 5% iodine & 10% K iodide; delivers 6.3 mg iodine per drop
Saturated solution of potassium iodide (SSKI)
• Dosage form: solution- 1 g/mL; delivers 38 mg iodine per drop of saturated solution
MOA: blocks hormone release, inhibits thyroid hormone synthesis
Diarrhea is associated with liquid KCl
Drugs can cause by 1 of 3 mechanisms:
o Stimulation of vasopressin release (i.e. nicotine, carbamazepine, Lithium, TCA’s, antipsychotic agents,
antineoplastic drugs, narcotics)
o Potentiation of antidiuretic action of vasopressin (i.e. chlorpropamide, methylxanthines, NSAIDs)
o Vasopressin analogs (i.e. oxytocin, DDAVP)
Deficient thyroid hormone production
Hashimoto’s disease is the cause of 90% of primary hypothyroidism
o Autoimmune resulting from cell- & antibody-mediated thyroid injury
S/Sx: cold intolerance, fatigue, somnolence, constipation, menorrhagia, myalgias, hoarseness, thyroid gland
enlargement or atrophy, bradycardia, edema, dry skin, weight gain
o Body slows down
Page 30
Thyroxine (T4) is the major hormone secreted by the thyroid, which is converted to the more potent
triiodothyronine (T3) in tissues
o Thyroxine secretion is stimulated by thyroid stimulating hormone (TSH)
o Diagnosis: TSH, T4
Drug therapy:
o Levothyroxine sodium, T4 (Synthroid, Levothroid, Levoxyl, Unithroid, Thyro-Tabs):
Usually DOC
Typical dose is 100-125 mcg po QD; reduce dose to 50 mcg for elderly & 25 mcg in patients with
CAD to reduce risk of precipitating angina
Dose changes are made within a 6-8 week interval
o Desiccated thyroid USP (Armour Thyroid, Nature-Throid, Westhroid)
o Liothyronine, T3 (Cytomel, Triostat)
o Liotrix, T4 & T3 in a 4:1 ratio (Thyrolar)
o Take 30 minutes before breakfast
o Don’t take antacids, calcium, or iron supplements within 4 hours of levothyroxine
o SE: tachycardia, arrhythmia, angina, MI, tremor, headache, nervousness, insomnia, diarrhea, vomiting,
weight loss, excessive sweating, hair loss
Body speeds up
o MOA: bactericidal; interferes with bacterial protein synthesis by binding to 30S & 50S ribosomal
subunits resulting in a defective bacterial cell membrane
o For serious aerobic gram + infections
o Poorly absorbed for GIT
o Renally eliminated by glomerular filtration
o Watch for oto- & nephrotoxicity
o Target serum concentrations:
Amikacin peak: 15-30 mcg/mL
Amikacin trough: <5 mcg/mL
Gentamicin & tobramycin peak: 4-10 mcg/mL
Gentamicin & tobramycin trough: <2 mcg/mL
o Amikacin (Amikin)
Least susceptible to resistance
Rule of nines (see gentamicin)
o Gentamicin (Garamycin):
Rule of eights to determine dosing interval
• SCr X 8
• i.e. 2 X 8 = 16- - dose Q16 hours
o Netilmicin (Netromycin)
o Tobramycin:
Should be given after dialysis and be a routine loading dose
Amphotericin B:
o Amphotericin B-conventional (Amphocin; Fungizone)
Premedicate 30-60 minutes prior with NSAID or APAP with or without diphenhydramine
• Or hydrocortisone
Reconstitute ONLY with sterile water without preservatives, not bacteriostatic water
Can add D5W
o Amphotericin B- lipid complex (Abelcet)
May also need to premedicate
o Amphotericin B-liposomal (AmBisome)
May also need to premedicate
o Amphotericin B Cholesteryl Sulfate Complex (Amphotec)
May also need to premedicate
ANC: absolute neutrophil count
Page 31
Neutrophils = bands + segs
i.e. 5 + 65 = 70
This means that 70% of the WBCs are neutrophils
If WBC= 14000 cells per cubic millimeter X 0.70 = 9800 neutrophil cells
Neutrophils are elevated with bacterial infections
Lymphocytes are elevated with viral infections
Not much elevation with fungal infections
o Granulocytes= bands + segs + basophils + eosinophils
Anti-influenza drugs:
o Amantadine (Symmetrel)
Blocks influenza A; no activity against influenza B
Effective when initiated within 48 hours of initial symptoms & continued for 7-10 days
SE: GI disturbances & CNS dysfunction, including dizziness, nervousness, confusion, slurred
speech, blurred vision, & sleep disturbances
May lower seizure threshold- avoid with seizure history
o Rimantadine (Flumadine)
Blocks influenza A; no activity against influenza B
Effective when initiated within 48 hours of initial symptoms & continued for 7-10 days
SE: GI disturbances & CNS dysfunction, including dizziness, nervousness, confusion, slurred
speech, blurred vision, & sleep disturbances
• Fewer SE than with amantadine
o Zanamivir (Relenza)
Blocks influenza A & B neuraminidases
Powder for inhalation (rotadisk with Diskhaler)
1-2 day improvement in symptoms in patients who are symptomatic for no longer than 48 hours
SE: headache, GI disturbances, dizziness, upper respiratory symptoms
o Oseltamivir (Tamiflu)
Block influenza A & B neuraminidases
1-2 day improvement in symptoms in patients who are symptomatic for no longer than 48 hours
Oral capsules & suspension
Anti-viral agents:
o Acyclovir (Zovirax):
Counseling: avoid sexual intercourse when lesions are present; this is not a cure for herpes; can
take with food; maintain adequate hydration (2-3 L/day); may cause lightheadedness or dizziness
o Valacyclovir (Valtrex):
Uses: treatment of herpes zoster (shingles), herpes labialis (cold sores) & genital herpes
MOA: rapidly & nearly completely converted to acyclovir by intestinal & hepatic metabolism;
inhibits DNA synthesis & viral replication by competing with deoxyguanosine triphosphate for
viral DNA polymerase & being incorporated into viral DNA
Reduce dose with renal dysfunction
o Fungus
o Amphotericin B (Amphotec, Abelcet, AmBisome), itraconazole (Sporanox), voriconazole (VFEND),
caspofungin (Cancidas)
NOT ketoconazole
o S/SX:
Males: urethritis, epdidymitis, proctitis, reiter syndrome, testicular pain
Females: cervictis, urethral syndrome, endometritis, PID, urethral or cervical discharge, pelvic
o Treatment: doxycycline, azithromycin, erythromycin (pregnant)
Tetracyclines & quinolones CI in children & pregnant women
Clostridium difficile:
Page 32
Gram +, anaerobic rod
DOC: metronidazole
Enterococcus faecalis: penicillin, ampicillin, vancomycin, linezolid, aminoglycosides, quinupristin & dalfopristin
(Synercid)- for vanco resistant enterococcus (VRE)
o Chloramphenicol, streptomycin, bactrim
o Gram +
o Clindamycin or cefazolin (cephalosporins ) will not treat
Escherichia coli:
o DOC: cefazolin (Ancef), cephalixin (Keflex, Biocef), cefotaxime (Claforan), gentamicin (Gentak)
o MOA: bactericidal; inhibit bacterial DNA topoisomemrase & disrupt bacterial DNA replication
o Can cause QT prolongation
o AE: crystalluria, tendon rupture
o Avoid PO in children under 18 years old- may cause cartilage growth suppression
o 2nd generation:
Ciprofloxacin (Cipro):
• MOA: inhibits DNA-gyrase in suspectible organisms; inhibits relaxation of supercoiled
DNA & promotes breakage of double-stranded DNA
• Cipro ear drops:
o Ciprofloxacin & dexamethasone (Ciprodex):
Treatment of acute otitis media in peds with tympanostomy tubes or
acute otitis externa in children & adults
o Ciprofloxacin & hydrocortisone (Cipro HC):
Treatment of acute otitis externa (swimmer’s ear)
o Neisseria gonorrhoeae
o Gram –
o Cefixime, ceftriaxone, ciprofloxacin, ofloxacin
Inhibit cell wall synthesis:
o Vancomycin, PCNs, cephalosporins
Legionella pneumophilia:
o DOC: azithromycin, clarithromycin, erythromycin
o Alternative: Rifampin, ciprofloxacin, levofloxacin
o Treat gram + & anaerobic infections
o Lincomycin (Lincocin)
o Clindamycin (Cleocin)
o Bacteriostatic
o Clarithromycin (Biaxin):
Should not be stored in the refrigerator
o Erythromycin:
Oral products:
• Erythromycin base (E-Mycin, Ery-Tab, PCE (polymer coated ery), Eryc)
o Sensitive to acid
o Coating on most products
o Administer on an empty stomach
• Erythromycin stearate (Erythrocin stearate, Wyamycin S)
o Properties similar to ery base but better absorbed
• Erythromycin estolate (Ilosone)
o Most hepatotoxic
Page 33
o Better absorbed than ery base
Erythromycin ethylsuccinate (Eryped, EES)
o Best absorbed form from GIT
o Available in liquid formulation
o 400 mg of EES = 250 mg erythromycin base
Parenteral products:
• Erythromycin lactobionate
• Erythromycin gluceptate
Topical products:
• Erythromycin (Staticin, Emgel)- for acne (colorless)
• Erythromycin (Ilotycin)- ophthalmic use
MOA: bacteriostatic macrolide antibiotic; may be bactericidal in high concentrations or when
used against highly susceptible organisms. It penetrates the bacterial cell membrane & reversibly
binds to the 50 S subunit of bacterial ribosomes
Reacts with theophylline by altering hepatic metabolism
• Also increases levels of carbamazepine, cyclosporine, triazolam, lovastatin, simvastatin,
o Azithromycin (Zithromax):
More gram – activity than erythromycin or clarithromycin
Suspension & capsules: take on an empty stomach
Tablet: with or without food
Not for children < 6 months old
o Inflammation of the meninges that is identified by an abnormal number of WBC in the CSF
o Causative organisms: many gram + & - species
Bacterial agents are associated with a large increase in WBCs, increased CSF protein, &
decreased CSF glucose
Fungal & viral agents exhibit smaller increases in CSF WBCs, smaller increases in CSF protein,
& limited decreases in CSF glucose
Mycoplasma pneumoniae:
o Erythromycin, tetracycline, doxycycline, fluoroquinolones, azithromycin, clarithromycin
o Daptomycin (Cubicin):
Used for resistant gram + infections
MOA: binds to bacterial membrane causing rapid depolarization of membrane potential which
leads to inhibition of protein, DNA & RNA synthesis, resulting in bacterial cell death
Dosing: 4-6 mg/Kg QD
o Linezolid (Zyvox):
Available dosage forms: IV, powder for oral suspension, tablet
For resistant gram + skin infections, vancomycin-resistant E. faecium
Monitor for myelosuppression, thrombocytopenia, & HTN (especially if used with tyraminecontaining foods)
Do not combine with SSRIs because of potential for serotonin syndrome
Bacteriostatic/bactericidal agent
Adjustment with renal dysfunction
o Metronidazole (Flagyl):
Use: treatment of bacterial vaginosis & trichomonias
MOA: after diffusing into the organism, interacts with DNA to cause a loss of helical DNA
structure & strand breakage resulting in inhibition of protein synthesis & cell death in susceptible
Avoid with etoh
o Nystatin:
Brand names: Bio-Statin; Mycostatin; Nystat; Nystop; Pedi-Dri
Antifungal agent for the treatment of susceptible cutaneous, mucocutaneous, & oral cavity fungal
infections caused by the Candida species
Page 34
MOA: binds to sterols in fungal cell membrane, changing the cell wall permeability allowing for
leakage of cellular contents
Systemic relief in 24-72 hours from candidiasis
Oral: poorly absorbed
Available dosage forms: cream, lozenge (DSC), ointment, powder for compounding, suspension,
tablet, vaginal tablet
Mycolog cream contains a corticosteroid (triamcinolone) as well as an antifungal (nystatin)
• Could be used for a patient with an ileostomy pouch
• Would also treat the inflammation that can occur from what are basically “tape burns”
o Vancomycin (Vanocin, Vancole):
MOA: inhibits bacterial cell wall synthesis by blocking glycopeptide polymerization through
binding tightly to D-alanyl-D-alanine portion of cell wall precursor
Alternative to other antimicrobials, including penicillins & cephalosporins for serious gram +
infections (resistant strains of strep, MRSA)
Watch for ototoxicity
Red man’s syndrome: rapid drop in BP accompanied by maculopapular rash in neck or chest area
often associated with rapid IV infusion
• Should be infused slowly >60 mins
Draw peak 1 hour after infusion has completed; draw trough just before next dose
Therapeutic peak: 25-40 mcg/mL (>80 toxic)
Therapeutic trough: 5-12 mcg/mL
Otitis media:
o 1st line drugs: ampicillin, amoxicillin, bacampicillin
o 2nd generation cephalosporin (cefaclor- Ceclor, cefuroxime- Ceftin, cefprozil-Cefzil, loracarbef-Lorabid)
o Zithromax, Biaxin, Bactrim
o Most common causative organisms: Streptococcus pneumoniae (pneumococcus), H. flu, moraxella
catarrhalis, pseudomonas, klebsiella
P. acne:
o Clindamycin, erythromycin, & tetracycline are effective
o Erythromycin & benzoyl peroxide (Benzamycin):
Apply BID
This product contains benzoyl peroxide which may bleach or stain clothing
Available as a topical gel or Benzamycin Pak (supplied with diluent containing alcohol
o Resistance to PCN is caused by beta lactamase enzyme production & alteration of PCN-binding proteins
Pseudomembranous enterocolitis (PE): Clostridium difficile overgrowth
o Caused by clindamycin & lincomycin
o Treat PE with fluid & electrolyte replenishment, oral metronidazole (IV if patient cannot take po), &/or
vancomycin (oral only)
o Aerobic, gram – bacillus
o Treatment:
Antipseudomonal PCN (mezlocillin, piperacillin, carbenicillin, ticarcillin)
Ceftazidime (Fortaz, Tazidime, Tazicef), Cefepime (Maxipime) + aminoglycoside
Quinolone + imipenem
Sulfonamide derivates:
o The only sodium sulfa salt suitable for ophthalmic use is sulfacetamide sodium (Sodium Sulamyd, Bleph10)
o Metabolized via acetylation
o Eliminated renally- good for UTIs
o Can result in crystalluria- drink sufficient amounts of water to prevent (2-3 L/day)
o Sulfamethoxazole & trimethoprim (Bactrim, Septra):
Page 35
Sulfamethoxazole interferes with bacterial folic acid synthesis & growth via inhibition of
dihydrogolic acid formation form paraaminobenzoic acid (PABA)
Trimethoprim inhibits dihydrofolic acid reduction to tetrahydrofolate resulting in
sequential inhibition of enzymes of the folic acid pathway
Staphylococcus aureus:
o DOC: dicloxacillin, nafcillin, oxacillin,
o PCN allergy: erythromycin, clindamycin, TCN, linezolid, synercid, vancomycin
Systemic fungal infection:
o Would NOT use nystatin
o Fluconazole (Diflucan)
o Initial therapy involves RIPE:
As therapy continues, therapy may go to RIP & then RI
May continue for 6-18 months
Rifampin (Rifadin, Rimactane):
• Potent enzyme inducer
• Orange discoloration of all bodily fluids- stains contacts
Isoniazid (Nydrazid):
• May cause vitamin B6 deficiency- give B6 (pyridoxine) with use
Ethambutol (Myambutol)
o Monitor TB drugs with:
Or other transferases
o Broad spectrum
o Doxycycline (Atridox, Doryx, Periostat, Vibra-Tabs, Vibramycin):
MOA: bacteriostatic effects by blocking the synthesis of bacterial proteins
Long-acting (BID) TCN
Eliminated via non-renal routes- good choice for renal impairment
DI with trivalent cations- Al (compatible with divalent cations)
o Normally found in the mouth
o It is a fungal infection of the mouth consisting of white spots
UTI- pyelonephritis:
o E. coli
o Bactrim, fluoroquinolones. Ampicillin + gentamicin
o UTI & sulfa allergy- treat with a FQ
Do not give FQ to children
Inflammatory Bowel Disease:
Ulcerative colitis: an idiopathic chronic inflammatory disease of the colon & rectum
Crohn’s disease: can affect any part of the tubular GIT & is characterized by transmural inflammation of the gut
Treat with:
o Sulfasalazine (Azulfidine, Sulfazine)
o Mesalamine (Asacol, Canasa, Pentasa, Rowasa)
o Olsalazine (Dipentum)
o Glucocorticords
o Immunosuppressive agents (6-mercaptopurine, azathioprine, methotrexate, cyclosporine)
o Antibiotics (metronidazole)
o Infliximab (Remicade)
Sulfasalazine (Azulfidine®):
o Used in the treatment of inflammatory bowel disease (ulcerative colitis) & RA
Page 36
Watch for sulfa allergy, salicylate allergy, & urinary discoloration
Sulfasalazine sulfapyridine + mesalamine (5-aminosalicyclic acid; 5-ASA)
5-ASA is more active
If patient cannot tolerate sulfasalazine because of a sulfa hypersensitivity, mesalamine (Asacol,
Pentasa, Rowasa) may be used
Immunosuppressive Therapy:
Calcineurin inhibitors:
o Cyclosporine (Sandimmune, Neoral)
o Tacrolimus (Prograf)
mTOR inhibitors:
o Sirolimus (Rapamune)
Antiproliferative agents:
o Azathioprine (Imuran)
o Mycophenolate mofetil (CellCept)
o Mycophenolate sodium (Myfortic)
o Leflunomide (Arava)
Monoclonal antibodies:
o Muromonab-CD3 (Orthoclone OKT 3)
o Basliximab (Simulect)
o Daclizumab (Zenepax)
Polyclonal antibodies:
o Anti-thymocyte globulin (Atgam): equine
o Anti-thymocyte globulin (Thymoglobulin): rabbit
Insomnia, Anxiety, or both:
o Most undergo oxidation to active metabolites in liver
o Lorazepam (Ativan), oxazepam (Serax), & temazepam (Restoril) undergo glucuronidation to inactive
Useful in elderly & those with liver disease
o Can experience seizures & delirium with sudden discontinuation
o Hypnotic agents:
Estazolam (ProSom)
Flurazepam (Dalmane)
Quazepam (Doral)
Temazepam (Restoril)
Triazolam (Halcion)
Trazodone (Desyrel):
o Antidepressant that is useful for severe anxiety or insomnia
o Highly sedating, causing postural hypotension & is associated with priapism
o Doses:
Sedation: 25-50 mg
Depression: 150 mg divided into 3 daily doses; max 600 mg/day
Zolpidem (Ambien):
o An imidazopyridine hypnotic agent
o MOA: has much or all of its actions explained by its effects on benzodiazepine receptors, especially the
omega-1 receptor
binds the benzodiazepine (BZ) receptor subunit of the GABA-A receptor complex
o No withdrawal symptoms, rebound insomnia or tolerance
o Rapid onset good for initiating & maintaining sleep
o SE: headache, daytime somnolence, GI upset
o Avoided in patients with obstructive sleep apnea
Zaleplon (Sonata)
o Nonbenzodiazepine hypnotic
Page 37
o MOA: interacts with benzodiazepine GABA receptor complex
o T1/2 is ~1 hour & has no active metabolites
o SE: drowsiness, dizziness, & impaired coordination
o Caution in those with compromised respiratory function
Eszopiclone (Lunesta):
o MOA: may interact with GABA-receptor complexes
OTC sleep aids:
o Doxylamine (Unisom)
o Diphenhydramine (Nytol, Sominex)
o Diphenhydramine + APAP (Tylenol PM, Unisom Pain Relief)
o Diphenhydramine + ASA (Bayer PM)
Autoimmune inflammatory condition
Systemic Lupus Erythematosus (SLE)
Drugs that can contribute: procainamide**, phenytoin, chlorpromazine, hydralazine*, quinidine, methyldopa, &
o Arthritis: NSAIDs or glucocorticoids
o Dermatologic complications: hydroxychloroquine (Plaquenil)
o Thrombocytopenia: glucocorticoid therapy
o Refractory cases: cyclophosphamide
Metabolic acidosis:
Give sodium acetate- acetate ion converts to bicarbonate
o Sodium citrate & citric acid
o Other brand names: Cytra-2 & Oracit
o AKA: Modified Shohl’s solution
o Use: treatment of metabolic acidosis; alkalinizing agent in conditions where long-term maintenance of an
alkaline urine is desirable
Also solution antacid pre-op if patient has eaten just before emergency surgery or delivery of
o Dosing: oral- 10-30 mL with water after meals (to avoid laxative effect) & at bedtime
o SE: N/V/D, hyperkalemia, tetany
o Selective serotonin receptor agonists that activate 5-HT1B/5-HT1D & to a lesser extent 5-HT1A/5-HT1F
o Agents:
Almotriptan (Axert): tablets; CYP450 & MAO metabolism
Sumatriptan (Imitrex): tablets, nasal spray, injection; MAO metabolism
• Can re-dose oral tablets & nasal spray if no response after 2 hours
• Can re-dose injection if no response after 1 hour
Eletriptam (Relpax): tablets; CYP 3A4 metabolism
Frovatriptan (Frova): tablet; renal 50%
Rizatriptan (Maxalt): tablet/wafer; MAO metabolism
Zolmitriptan (Zomig): tablet/wafer; CYP450 & MAO metabolism
Naratriptan (Amerge): tablets; renal 70% & CYP450
o SQ sumatriptan has the fastest onset followed by sumatriptan nasal spray
o Rizatriptan may have a slightly faster onset of action than the others
o Migraine recurrence rates may be lower with long half-life triptans such as naratriptan & frovatriptan
o SE: tingling & paresthesias; sensations of warmth in the head, neck, chest, & limbs; dizziness; flushing;
neck pain or stiffness
o Do not give sumatriptan to patients who have risk factors for CAD
Page 38
o CI: in patients with hx of ischemic heart disease, MI, uncontrolled HTN, or other heart disease; pregnancy
Ergot derivatives:
o CI: pregnancy, peripheral vascular disease, CAD, sepsis, hepatic or renal impairment
o Dihydroergotamine (DHE 45, Migranal):
Migraines: with or without aura
MOA: ergot alkaloid alpha-adrenergic blocker directly stimulates vascular smooth muscle to
vasoconstrict peripheral & cerebral vessels; also has effects on serotonin receptors
• 5-HT1D receptor agonist
Max: 6 mg/week
Patient takes too much: N/V/D, dizziness, paresthesia, peripheral ischemia, peripheral
Available dosage forms: injection & intranasal spray
Miscellaneous Drugs:
Acetylcysteine (Mucomyst, Acetadote):
o MOA: exerts mucolytic action through its free sulfhydryl group which opens up the disulfide bonds in
the mucoproteins thus lowering mucous viscosity; thought to reverse APAP toxicity by providing
substrate for conjugation with the toxic metabolites
Adalimumab (Humira):
o Tumor necrosis factor (TNF) blocking agent
o MOA: binds to human tumor necrosis factor alpha (TNF-alpha) receptor sites
Elevated TNF levels in the synovial fluid are involved in pathologic pain
o Use: treatment of active RA in patients with inadequate response to one or more DMARDs; psoriasis
o Dose: 40 mg SQ EOW
o Before starting therapy: TB test, measure rheumatoid factor, PT
Adefovir (Hepsera):
o Antiretroviral agent; reverse transcriptase inhibitor (nucleoside)
o MOA: acyclic nucleotide reverse transcriptase inhibitor (adenosine analog) which interferes with HBV
viral RNA dependent DNA polymerase resulting in inhibition of viral replication
o Use: treatment of chronic hepatitis B
Atropine (AtroPen; Atropine-Care; Isopto; Sal-Tropine):
o AtroPen formulation is available for use primarily by the department of defense
o MOA: blocks the action of acetylcholine at parasympathetic sites in smooth muscle, secretory glands &
the CNS; increases CO, dries secretions, antaonizes histamine & serotonin
Bismuth subsalicylate, metronidazole, tetracycline (Helidac):
o If patient has + urea breath test indicating H. pylori present
Chlorhexidine (Periogard):
o Antibacterial agent for oral rinse
o Bactericidal
o Uses: disinfectant; gingivitis; periodonitis; inhibits plaque formation
Cromolyn (NasalCrom):
o Dose: use 1 spray in each nostril 3-4 times per day
Cyclosporin (Gengraf, Neoral, Restasis, Sandimmune):
o Neoral & Sandimmune are NOT therapeutically equivalent
o Immunosuppressant agent
o MOA: inhibition of production & release of interleukin II & inhibits interleukin II-induced activation or
resting T-lymphocytes
Desmopressin (DDAVP, Stimate):
o Vasopressin analog
o Uses: diabetes insipidus; control bleeding in hemophilia A & van Willebrand disease; primary noctural
o Strengths/dosage forms:
Injection (IV): 4 mcg/mL
Solution, intranasal: 100 mcg/mL
Page 39
Dicyclomine (Bentyl);
o MOA: anticholinergic agent
o Uses: treatment of functional disturbances of GI motility such as irritable bowel syndrome
o NOT used for GERD
Etancercept (Enbrel):
o Disease modifying agent
o MOA: binds to TNF & blocks its interaction with cell surface receptors
TNF blocker
o Use: moderate-severe RA; chronic plaque psoriases
o Dose: 25 mg injection SQ twice weekly or 50 mg injection SQ once weekly
o Initial storage of drug: in refrigerator (not frozen)
o Stability of vials after reconstitution: 14 days in refrigerator
o Allow prefilled syringes 15-30 minutes at room temperature prior to injection
o Some foaming is normal
o MOA: expectorant which acts by irritating the gastric mucosa & stimulating respiratory tract secretions,
thereby increasing respiratory fluid volumes & decreasing mucus viscosity
Hyaluronate (Hyalgan, Biolon, Healon, Hylaform, Orthovisc, Provisc, Restylane, Supartz, Synvisc, Vitax):
o MOA: sodium hyaluronate is a polysaccharide which is distributed widely in the extracellular matrix of
connective tissue in man. It forms a viscoelastic solution in water (at physiological pH & ionic strength)
which makes it suitable for aqueous & vitreous humor in ophthalmic surgery & functions as a tissue &/or
joint lubricant
o Use:
intra-articular injection (Synvisc)- treatment of pain in OA in knee in patients who have failed
nonpharmacologic treatment & simple analgesics
• No weight bearing exercise for 48 hours
Intradermal- correction of moderate to severe facial wrinkles
Ophthalmic- surgical aid in cataract extraction, intraocular implantation, corneal transplant,
glaucoma filtration, & retinal attachment surgery
Topical- management of skin ulcers & wounds
Hydroxyzine (Atarax, Vistaril):
o MOA: competes with histamine for H1 receptor sites on effector cells in the GIT, blood vessels, &
respiratory tract; possesses skeletal muscle relaxing, bronchodilator, antihistamine, antiemetic, &
analgesic properties
o Use: treatment of anxiety; preoperative sedative; antipruritic
o Not to be confused with Hydralazine
Interferon beta 1b (Betseron):
o Use: treatment of MS
o Can cause hepatotoxicity- monitor LFTs
Isotretinoin (Accutane, Amnesteem, Clarais, Sotret):
o Retinoic acid derivative
o MOA: reduces sebaceous gland size & reduces sebum production; regulates cell proliferation &
o Use: treatment of sever recalcitrant nodular acne unresponsive to conventional therapy
o RiskMAP, S.M.A.R.T., S.P.R.I.T., I.M.P.A.R.T. programs
Cannot be dispensed unless the rx is affixed with a yellow, self-adhesive qualification sticker
filled out by the prescriber
Telephone, fax, or computer-generated rxs are no longer valid
Rx cannot be written for more than a 1-month supply, must be dispensed with a patient education
Females must have their rxs filled within 7 days of the qualification date- considered expired if >
o Pregnancy risk factor: X
Females must have 2 methods of contraception; 1 month prior to starting therapy & 1 month after
discontinuation of therapy
Page 40
Therapy is begun after 2 negative pregnancy tests
SE: increased triglycerides, elevated blood glucose, photosensivitivity
Avoid additional vitamin A supplements
Dose: 0.5-2 mg/Kg/day in 2 divided doses
Take with food; limit exercise while on therapy; capsules can be swallowed, or chewed & swallowed;
capsule may be opened with a large needle & contents placed on applesauce or ice cream
o Excerbation of acne may occur during the 1st weeks of therapy
o Accutane, Amnesteem, & Sotret contains soybean oil (Claravis does not)
Lansoprazole (30 mg), amoxicillin (1 g), clarithromycin (500 mg) (Prevpac):
o For H. pylori
o Taken together BID for 10-14 days
Leflunomide (Arava):
o Disease modifying agent
o MOA: inhibits pyrimidine synthesis, resulting in antiproliferative & anti-inflammatory effects
o Use: treatment of active RA; indicated to reduce signs & symptoms, & to retard structural damage &
improve physical function
Luride: source of fluoride to prevent dental caries
o Supplied as sodium fluoride in chewable tablets that provide 0.25 mg, 0.5 mg, & 1 mg of fluoride ion per
o Prolonged ingestion with excessive doses may result in dental fluorosis (staining or hypoplasia of the
enamel of the teeth) & osseous changes
Malathion (Ovide):
o Class: organophosphate; pediculicide
o Uses: pediculosis capitis; lice
o MOA: acts via cholinesterase inhibition. It exerts both lousicidal & ovicidal actions in vitro.
o Safety not established in children under 6 years old
o Lotion
Mannitol (Osmitrol, Resectisol):
o Osmotic diuretic
o MOA: increases osmotic pressure of glomerular filtrate, which inhibits tubular reabsorption of water &
electrolytes & increases urinary output
Mebendazole (Vermox):
o Anthelmintic agent
o MOA: selectively & irreversibly blocks glucose uptake & other nutrients in susceptible adult intestinedwelling helminthes
o Dosing:
Pinworms: 100 mg po ASD; may need to repeat after 2 weeks; treatment should include family
members in close contact with patient
Whipworms, roundworms, hookworms: 1 tablet BID, morning & evening on 3 consecutive days;
if patient is not cured within 3-4 weeks, a 2nd course of treatment may be administered
Capillariasis: 200 mg BID for 20 days
o Strengths/dosage forms:
Tablet, chewable: 100 mg
Methotrexate (Rheumatrex; Trexall):
o MOA: inhibits dihydrofolate reductase causing interference with DNA synthesis, repair, & cellular
o Juvenile RA: oral, IM: 10 mg/m2 once weekly
o Does cause alopecia
o Causes myelosuppression & thrombocytopenia
NOT thrrombocytosis (increased PLT)
Misoprostol (Cytotec):
o MOA: synthetic prostaglandin E1 analog that replaces the protective prostaglandins consumed with
prostaglandin-inhibiting therapies (i.e. NSAIDs); has been shown to induce uterine contractions
o Dosing:
Prevention of NSAID-induced ulcers: 200 mcg po QID with food (to decrease diarrhea)
Page 41
Labor induction or cervical ripening: intravaginal- 25 mcg (1/4 of a 100 mcg tablet)
• Do not use in patients with previous cesarean delivery or prior major uterine surgery
Fat absorption in CF (unlabeled use): 100 mcg QID (ages 8-16)
Nimodipine (Nimotop):
o MOA: calcium channel blocker
o Use: spasm following subarachnoid hemorrhage from ruptured intracranial aneurysms
o Has a greater effect on cerebral arteries- may be due to the drug’s increased lipophilicity
o Dosing: 60 mg po Q4h x 21 days; start 96 hours after subarachnoid hemorrhage
o If the capsules cannot be swallowed, the liquid may be removed by making a hole in each end of the
capsule with an 18-guage needle & extracting the contents via syringe
Oxybutynin (Ditropan):
o Urinary antispasmodic agent
o MOA: Non-selective muscarinic receptor antagonist with a higher affinity for M1 & M3 receptors
Increases bladder capacity, decreases uninhibited contractions, & delays desire to void
o Dosage forms available: syrup, tablet (IR, XR), patch (Oxytrol)
Palivilizumab (Synagis):
o Use: monoclonal antibody used for prevention of serious lower respiratory tract disease caused by
respiratory syncytial virus (RSV) in infants & children < 2 years
o MOA: exhibits neutralizing & fusion-inhibitory activity against RSV
Ribavirin (Copegus, Rebetol, Ribasphere, Virazole) also used to treat RSV
o Nondepolarizing neuromuscular blocking agent
o MOA: blocks neural transmission at the myoneural junction by binding with cholinergic receptor sites
o Onset: 2-4 minutes
o Duration after single dose: 40-60 minutes
o Use: adjunct to general anesthesia to facilitate endotracheal intubation & to relax skeletal muscles during
surgery; does not relieve pain or produce sedation
o DOC for neuromuscular blockade EXCEPT in patients with renal failure, hepatic failure, or
cardiovascular instability
o AE: increased pulse rate, elevated BP & CO, edema, flushing, rash, bronchospasm, hypersensitivity rxn
Peginterferon Alfa-2a (Pegasys):
o Use: hepatitis C
o Refrigerate; protect from light
Permethrin(Acticin, Elimite, Nix Creme Rinse, Pronto, Rid, A200 Lice Control)
o OTC available with same ingredient: Nix
o Calcium acetate
o Use:
Oral: control of hyperphosphatemia in end-stage renal failure; does not promote aluminum
IV: calcium supplementation in parenteral nutrition therapy
o MOA: combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the
Physostigmine (Antilirium):
Propofol (Diprivan):
o General anesthetic; no analgesic properties
o Avoid abrupt discontinuation- titrate slowly
o Propofol emulsion contains soybean oil, egg phosphatide & glycerol
o “Propofol infusion syndrome”: symptoms include sever, sporadic metabolic acidosis &/or lactic acidosis
which may be associated with tachycardia, myocardial dysfunction, &/or rhabdomyolysis
o Short duration of action: 3-10 minutes
o If on concurrent parenteral nutrition, may need to adjust the amount of lipid infused
o Provides 1.1 kCal/mL
Page 42
o Magaldrate (antacid) & simethicone (antiflatulent) combination
o Substitutes can be found in the Non-Prescription Handbook & Facts & Comparisons
o Nondepolarizing neuromuscular blocker agent
o MOA: blocks acetylcholine from binding to receptors on motor endplate by inhibiting depolarization
o Onset: 2-4 minutes
o DOA: 30-45 minutes
o Use: adjunct to general anesthesia to facilitate endotracheal intubation & to relax skeletal muscles during
surgery; does not relieve pain or produce sedation
o AE: bradycardia, edema, flushing, hypersensitivity rxn, hypotension, tachycardia, rash
Miscellaneous Facts:
Danger of decreasing DKA too fast: cerebral edema
Genetic polymorphism exists as acetylation
Albumin is important for measuring calcium levels
o Corrected calcium = serum calcium + 0.8(4 – patient’s albumin)
Caffeine treats respiratory distress in neonates
Emergency bee sting kit:
o Epinephrine & APAP
o EpiPen auto-Injector
0.3 mg SQ dose of 1:1000 epinephrine in a 2 mL disposable prefilled injector
Liposyn III (fat emulsion) is stored at room temperature
MedWatch: a list of reported side effect
o Completely voluntarily reported
Stain dermatologists use for fungus identification: KOH
Kayexlate + sorbitol use: to prevent constipation
o Store at room temperature
Hypercalcemia: almost always caused by increased entry of Ca into the extracellular fluid & decreased renal Ca
o More that 90% of cases are due to primary hyperparathyroidism or malignancy
Hypocalcemia in renal impairment:
o Phosphorus & calcium levels are altered due to:
Phosphorus retention, resulting in a rise in serum phosphorus levels & a reciprocal fall in calcium
levels, with resultant stimulation of parathyroid hormone (PTH) secretion
Decreased generation of 1,25-dihyroxyvitamin D3, further contributing to low serum calcium
levels & decreasing suppression of PTH
o Addition of a phosphate binder prevent GI phosphate absorption:
Calcium carbonate 500-1000 mg po with meals
Sevelamer (Renagel): lacks aluminum & calcium
Cheilitis: inflammation of the lips
Herpes simplex I (cold sore): avoid the sunlight
Goodpasture’s syndrome: glomerulonephritis associate with pulmonary hermorrhage & circulating antibodies
against basement membrane antigens
Myasthenia Gravis:
An autoimmune disorder that involve antibody-mediated disruption of postsynaptic nicotinic acetylcholine
receptors at the neuromuscular junction & is often associated with thymus tumors
o Anticholinesterase drugs:
o Thymectomy
o Immunosuppressive drugs
High-dose prednisone
Page 43
Orange Book:
AKA: Approved Drug Products with Therapeutic Equivalence Evaluations
o A: Drug products that FDA considers to be therapeutically equivalent to other pharmaceutically
equivalent products, i.e., drug products for which:
there are no known or suspected bioequivalence problems. These are designated AA, AN, AO,
AP, or AT, depending on the dosage form; or
actual or potential bioequivalence problems have been resolved with adequate in vivo and/or in
vitro evidence supporting bioequivalence. These are designated AB
AA Products in conventional dosage forms not presenting bioequivalence problems
AB, AB1, AB2, AB3... Products meeting necessary bioequivalence requirements
AN Solutions and powders for aerosolization
AO Injectable oil solutions
AP Injectable aqueous solutions &, in certain instances, intravenous non-aqueous solutions
AT Topical products
o B: Drug products that FDA at this time, considers NOT to be therapeutically equivalent to other
pharmaceutically equivalent products, i.e.,
drug products for which actual or potential bioequivalence problems have not been resolved by
adequate evidence of bioequivalence. Often the problem is with specific dosage forms rather
than with the active ingredients. These are designated BC, BD, BE, BN, BP, BR, BS, BT, BX, or
B* Drug products requiring further FDA investigation & review to determine therapeutic
BC Extended-release dosage forms (capsules, injectables & tablets)
BD Active ingredients & dosage forms with documented bioequivalence problems
BE Delayed-release oral dosage forms
BN Products in aerosol-nebulizer drug delivery systems
BP Active ingredients & dosage forms with potential bioequivalence problems
BR Suppositories or enemas that deliver drugs for systemic absorption
BS Products having drug standard deficiencies
BT Topical products with bioequivalence issues
BX Drug products for which the data are insufficient to determine therapeutic equivalence
T scores are used for diagnosis:
o Osteopenia: T score -1 to -2.5 SD below the young adult mean
o Osteoporosis: T score -2.5 SD below the young adult mean
o Could worsen esophagitis
o Take with a full glass of water fir thing in the AM & at least 30 minutes before the 1st food or beverage of
the day
o Maximize therapy by taking calcium + vitamin D
o Alendronate (Fosmax):
Prevention dose: 5 mg QD or 35 mg Q week
Treatment dose: 10 mg QD or 70 mg Q week
Dosage forms: solution & tablet
o Ibandronate (Boniva):
Prevention dose: 2.5 mg QD; 150 mg Q month may be considered
Treatment dose: 2.5 mg QD or 150 mg Q month
o Risedronate (Actonel):
Prevention dose: 5 mg QD or 35 mg Q week may be considered
Treatment dose: 5 mg QD or 35 mg Q week
Page 44
Selective Estrogen Receptor Modulator:
o Raloxifene (Evista):
MOA: estrogen receptor agonist at the skeleton decreases resorption of bone & overall bone
60 mg QD for treatment & prevention of osteoporosis
SE: increased risk of thromboembolism, hot flashes, nausea, dyspepsia, weight gain
Teriparatide (Forteo):
o Parathyroid hormone (PTH) analog for osteoporosis
o MOA: stimulates osteoblast function, increases GI calcium absorption, increases renal tubular
reabsorption of calcium
o Dosage: injection
o Storage: refrigerate; discard pen 28 days after 1st injection
Aluminum hydroxide (ALternaGel, Amphojel):
o Use: for treatment of hyperacidity & hyperphosphatemia
o MOA: neutralizes hydrochloride in stomach to form Al(Cl)3 salt + H2O
o Dose:
Hyperphosphatemia: 300-600 mg TID with meals (within 20 minutes of meal)
Hyperacidity: 600-1200 mg between meals & at bedtime
o Aluminum may accumulate in renal impairment
o Dose should be followed with water
Antidiarrheal agents:
o Bismuth subsalicylate (Kaopectate)
Has both antisecretory & antimicrobial actions while possibly providing anti-inflammatory action
as well
Atopic dermatisis:
o Hydrocortisone
Capsacin (Zostrix, Capzasin):
o MOA: induces the release of substance P, the principle chemomediator of pain impulses from the
periphery to the CNS; after repeated application, the neuron is depleted of substance P
o Apply to the affected area at least 3-4 times/day
If applied less than this, decreased efficacy
o Strength: 0.025%, 0.075%
Diaper rash:
o Breast-fed infants have less diaper rash than do bottle-fed infants
o Skin protectants to treat:
Allantoin, calamine, cod liver oil (in combination), dimethicone, kaolin, lanolin (in combination),
mineral oil, petrolatum, talc, topical cornstarch, white petrolatum, zinc oxide, zinc oxide ointment
Loratidine (Claritin, Alavert):
o Nonsedating antihistamine
o Patients with liver or renal impairment should start with a lower dose (10 mg QOD)
o Do not use in children <2
o Dosing:
2-5 years old: 5 mg QD
>6: 10 mg QD
o Take on an empty stomach
o Available as: syrup, tablet, rapidly disintegrating tablets
Nicotine Replacement therapy:
o Products: patch, gum, lozenge, inhaler
Ostomy care:
o Three basic types of ostomies:
Colostomy (most common)
Urinary diversion
Page 45
Effect of food on stoma output:
Foods that thicken:
• Applesauce, bananas, bread, buttermilk, cheese, pasta, potatoes, pretzels, rice yogurt
Foods that loosen:
• Alcohol, chocolate, beans, fried or greasy foods, spicy foods, leafy veg
Foods that cause stool odor:
• Asparagus, beans, cheese, eggs, fish, garlic
Foods that cause urine odor:
• Asparagus, seafood, spices
Foods that combat urine odor:
• Buttermilk, cranberry juice, yogurt
o Local complications:
Local irritation: can occur because the output from the intestines or kidneys can irritate the skin
around the stoma
• Patient can use: karaya powder, pectin base powder, ostomy creams, or barriers to
protect the skin
Alakaline dermatitis: occurs in patients with urinary diversions because of the alkaline nature of
the output
• Major cause of blood in the pouch because it renders the stoma extremely friable
• Treatment is acidification of the urine (cranberry juice 2-3 quarts daily)
Excoriation: caused by erosion of the epidermis by digestive enzymes
• The eroded or denuded epidermis may bleed, & is painful when touched when applying
the appliance
• Treatment: karaya or pectin-based powder may be applied to the peristomal skin prior to
application of the pouch, more frequent changing of the pouch
Infection: candida species
• 2% miconzaole powder or nystatin powder
o Fitting an ostomy:
Pouch opening may be cut to fit or presized
• If they are cut to fit, the stoma pattern is traced onto the skin barrier-wafer surface of the
pouch & then cut out before being applied
The diameter of the round stoma is measured at the base, where the mucosa meets the skin, which
is considered the widest measurement
Oval stomas should be measured at both their widest & narrowest diameters
A stoma may swell if the appliance fits too tightly or slips, or if the patient falls or experiences a
hard blow to the stoma
Other consideration include: body contour, stoma location, skin creases & scars, & type of
To prevent leakage, the pouch should be emptied when it is 1/3 – 1/2 full
The flange & skin barrier may be left in place for 3-7 days, depending on the condition of the skin
& skin barrier
Water will not enter the stoma so it is not necessary to cover it while swimming, bathing, or
Oxymetazoline (Afrin):
o Adrenergic agonist; vasoconstrictor
o Rebound congestion may occur with extended use (>3 days)
o Caution in the presence of HTN, DM, hyperthyroidism, CAD, asthma
o Increased toxicity with MAOI
o Do not use if it changes color or becomes cloudy
o MOA: stimulates alpha-adrenergic receptors in the arterioles of the nasal mucosa to produce
o Approved for >6 years old
Poison ivy:
o Topical anesthetics: benzocaine & pramoxine
o Hydrocortisone
Page 46
Aluminum acetate (Burrow’s solution, Domeboro Powder), zince oxide, zinc acetate, sodium
bicarbonate, calamine, witch hazel (hamamelis waters)
o Colloidal oatmeal baths to help to provide skin hydration, to aide in cleansing or removing skin debris, &
to allay the drying & tightening symptoms
o Antihistamines
o Guaifenesin: an expectorant used to help loosen phlegm & thin bronchial secretions to make coughs
more productive
o Plantar warts:
Clear Away Wart Remover: Salicyclic acid 40%
Wart off
Dr. Scholls Clear Away
Pure Mu Agonists: strong opioids for severe pain
o Fentyl:
Sublimaze: injection
Duragesic: transdermal patch (change Q 3 days)
• 5 patches per box
Actiq: lozenge
o Hydromorphone (Dilaudid):
Can cause seizures
Dosage forms: tablet, liquid, suppository, injection (a slight yellowish discoloration has not been
associated with loss of potency
o Levoophanol (Levo-Dromoran)
Dosage forms: tablet & injection
o Meperidine (Demerol, Meperitab):
MOA: binds to opiate receptors in the CNS, causing inhibition of ascending pain pathways,
altering the perception of & response of pain
Hepatic metabolite, normeperidine, can buildup & cause seizures
• Do not use in patients with seizure disorders
Avoid use with MAOIs
• Isocarboxazid (Marplan)
• Selegiline (Eldepryl, Deprenyl)- Parkinson’s
• Phenelzine (Nardil)
• Tranylcypromine (Parnate)
o Methadone (Dolophine, Methdose):
Dosage forms: tablet, liquid, injection
o Morphine (Astramorph/PF, Avinza, DepoDur, Duramorph, Infumorph, Kadian, MS Contin (ER or SR),
MSIR (IR), Oramorph SR, RMS, Roxanol):
MOA: binds to opiate receptors in the CNS, causing inhibition of ascending pain pathways,
altering the perception of & response of pain
Can cause: hypotension, bradycardia, respiratory depression
Vasodilatory properties
Dosage forms:
• Capsules (ER, SR)
• Infusion
• Injection (ER liposomal suspension for lumbar epidural injection)
• Injection, solution
• Solution
• Suppository
• Tablet (CR, ER, SR)
o Oxycodone (OxyIR, Roxicodone, Percocet, OxyContin (CR)):
Page 47
Oxymorphone (Numorphan-suppository)
Dosage forms: injection & suppository
Pure mu agonists: mild to moderate pain
o Codeine (Tylenol #3)
o Hydrocodone:
With APAP:
• Vicoden 5/500; Vicoden ES 7.5/750; Lorcet or Vicodin HP 10/650; Lortab 2.5/500,
5/500, 7.5/500, 10/500; Norco 5/325, 7.5/325, 10/325
With IBU:
• Vicoprofen 7.5/200
o Propoxyphene:
• Darvocet-N-50 (50/325); Darvocet-N-100 (100/650)
• Darvon 32, 65 mg
o Buprenorphine (Buprenex)
o Butorphanol (Stadol)
Available as: injection & nasal spray
o Dezocine (Dalgan)
o Nalbuphine (Nubain)
Injection only
o Pentazocine:
50 mg tablet: Talwin
50 mg/naloxone 0.5 mg tablet: Talwin NX
12.5/ASA 325 tablet: Talwin Compound
o Tramadol (Ultram)
400 mg max
o Ultracet (Tramadol/APAP 37.5/325)
o Indomethacin (Indocin):
• Inflammatory/RA: 25-50 mg/day 2-3 times/day; max 200 mg/day
Dosage forms: IR & SR capsule, injection & suspension
o Ketorolac (Toradol):
Do NOT use for more than 5 days
Acular: ophthalmic dosage form
o Nabumetone (Relafen):
For OA & RA
Dosing: 1000 mg/day; an additional 500-1000 mg may be needed in some patients; may be
administered QD or BID; NMT 2000 mg/day
Take with food or milk to decrease GI upset
o Diclofenac (Voltaren)
o Etodolac (Lodine)
o Tolmetin (Tolectin)
o Sulindac (Clinoril)
o Fenoprofen (Nalfon)
o Flurbiprofen (Ansaid)
o Ibuprofen (Motrin)
o Ketoprofen (Orudis, Oruvail-SR)
o Naproxen (Naprosyn)
o Oxaprozin (Daypro)
o Meclofenamate (Meclomen)
o Piroxicam (Feldene)
o Celecoxib (Celebrex)
Page 48
o Interferes with ACEIs, ARBs, & diuretics
o Usual ratio is Morphine 8 to dilaudid 1
o Methadone 10 mg = hydromorphone 7.5 mg (po) & 1.5 mg (IM)
A chronic progressive neurologic disorder with symptoms that present as a variable combination of rigidity,
tremor, bradykinesia, & changes in posture & ambulation
Primary Parkinson’s- no identified cause
Secondary Parkinson’s- may be the result of drug use (i.e. reserpine, metoclopramide, antipsychotics), infections,
trauma, or toxins
Progressive degeneration of the substantia nigra in the brain with a decrease in dopaminergic cells
Drug therapy:
o Want medications that will increase dopamine or dopamine activity by directly stimulating dopamine
receptors or by blocking acetylcholine activity, which results in increased dopamine effects
o Carbidopa-levodopa (Sinemet):
MOA; levodopa increases DA; carbidopa prevents metabolism of levodopa allowing more to
enter the blood brain barrier
Take on an empty stomach & eat shortly after to prevent N/V
o Direct stimulation of DA receptors:
Bromocriptine (Parlodel)
Pergolide (Permax)
Pramipexole (Mirapex)
Ropinirole (Requip)
o Selegiline (Eldepryl, Carbex, Atapryl, Selpak):
MOA: inhibits MAOB; increases DA & 5-HT
o Inhibits COMT; increases DA:
Entacapone (Comtan)
Tolcapone (Tasmar)
o Amantadine (Symmetrel):
MOA: may increase presynaptic release of DA, blocks reuptake
o Blocks acetylcholine, may balance DA:
Benztropine (Cogentin)
Trihexyphenidyl (Artane)
o Vitamin E- antioxidant; mixed results
EES ointment given in neonate to prevent gonorrhea infection in the eyes
Vitamin K is given to babies until they can produce their own
Colfosceril (Exosurf): respiratory surfactant
o Administered intrathecheally
Neural tube defects are a result of a decrease in folic acid (while pregnant)
o <12 years: 10-15 mg/Kg/dose Q 4-6 hours prn (NMT 5 doses: 2.6 g in 24 hours)
o 6 months – 12 years
Temperature <102.5°F: 5 mg/Kg/dose
Temperature >102.5°F: 10 mg/Kg/dose
Q 6-8 hours; max daily dose: 40 mg/Kg/day
Theophylline can be used as a respiratory stimulant in babies
Bioavailability: refers to the rate & extent of absorption
o Absolute bioavailability: the fraction (or %) of a dose administered non-IV (or extravascularly) that is
systemically available (compared to an IV dose)
Page 49
If given orally, absolute bioavailability (F) is:
o Relative bioavailability: the fraction of a dose administered as a test formulation that is systemically
available as compared to a reference formulation:
F = (AUCtest formulation/AUCreference) X ( Dreference/Dtest formulation)
o Glycerin, talc, starch, witch hazel = suspension
Talc is not soluble
Starch is not very soluble
o To make a oleaginuous base use: white petrolatum
o 0.22 micron filter does NOT remove pyrogens
Methylcellulose: a suspending agent (semisynthetic hydrocolloids)
Selected dosage forms:
o Butorphanol (Stadol)
Injection, intranasal spray
o Calcitonin (Miacaclin)
Injection, intranasal spray
Stored in refrigerator
o Desmopressin (DDAVP, Stimate)
Injection, intranasal spray, tablets
o All three above come in a nasal inhaler
o Budesonide:
Capsules (Entocort), nasal suspension, powder for oral inhalation, suspension for oral inhalation
o Fluticasone:
Aerosol for oral inhalation, cream (Cutivate), ointment, powder for oral inhalation, suspension
intranasal spray
Rizatriptan (Maxalt), loratadine (Claritin), ondansetron (Zofran) are all available as an orally disintegrating tablet
Mg sterate: lubricant in tablet
o Excess will cause alteration in tablet dissolution due to decreased rate of tablet break down (would slow
o Pick pair of drugs with one acid & one base
o Liposyn-II
Fat emulsion
May be stored at room temperature
Do not store partly used bottle for later use
Do not use if emulsion appears to be oiling out
o Room temperature antibiotic suspensions:
Clarithromycin (Biaxin); sulfamethoxazole-trimethoprim (Bactrim); azithromycin (Zithromax);
cefdinir (Omnicef)
Furosemide has a pka of 3.7 at physiologic pH will it be 25% ionized, 75% ionized, all ionized, all ionized or
can’t determine?
o Furosemide (one word generic name) is an acid; acids are all non-ionized at acidic pH but are ionized at
basic pH; physiologic pH is 7.4 which is quite alkaline compared to 3.7; means furosemide ionized to
non-ionized ratio would be > 1:1000, so totally ionized
o Naproxen pka = 4.2 what would happen at plasma pH?
Same as above because naproxen is also an acid
Typical pharmaceutical ingredients:
o Antifungal preservative: used in liquid & semisolid formulations to prevent growth of fungi
Ex: benzoic acid, butylparaben, ethylparaben, sodium benzoate, sodium propionate
o Antimicrobial preservative: used in liquid & semisold formulations to prevent growth of microorganisms
Ex: benzalkonium chloride, benzyl alcohol, cetylpyridinium chloride, phenyl ethyl alcohol
Page 50
Antioxidant: used to prevent oxidation
Ex: ascorbic acid, ascorbyl palmitate, sodium ascorbate, sodium bisulfate, sodium metabisulfite
Emulsifying agent: used to promote & maintain dispersion of finely divided droplets of a liquid in a
vehicle in which it is immiscible
Ex: acacia, cetyl alcohol, glyceryl monostearate, sorbitan monostearate
Surfactant: used to reduce surface or interfacial tension
Ex: polysorbate 80, sodium lauryl sulfate, sorbitan monopalmitate
Plasticizer: used to enhance coat spread over tablets, beads, & granules
Ex: glycerin, diethyl palmitate
Suspending agent: used to reduce sedimentation rate of drug particles dispersed throughout a vehicle in
which they are not soluble
Ex: Carbopol, hydroxymethylcellulose, hydroxypropyl cellulose, methylcellulose, tragacanth
Binder: used to cause adhesion of powder particles in tablet granulations
Ex: acacia, alginic acid, ethylcellulose, starch, povidone
Diluent: used as fillers to create desired bulk, flow properties, & compression characteristics in tablet &
capsule preparations
Ex: kaolin, lactose, mannitol, cellulose, sorbitol, starch
Disintegrant: used to promote disruption of solid mass into small particles
Ex: microcrystalline cellulose, carboxymethylcellulose calcium, sodium alginate, sodium starch,
glycolate, alginic acid
Glidant: used to improve flow properties of powder mixture
Ex: colloidal silica, cornstarch, talc
Lubricant: used to reduce friction during tablet compression & facilitate ejection of tablets from the die
Ex: calcium stearate, magnesium stearate, mineral oil, stearic acid, zinc stearate
Humectant: used for prevention of dryness of ointment & creams
Ex: glycerin, propylene glycol, sorbitol
Tests used to test for drug absorption in GI:
o Dissolution
o Disintegration: must occur before dissolution can occur
o Hardness: hardness of a tablet influences its ability to break apart in the stomach
o All can be tested in vitro
Tocolytics (stops labor):
o Magnesium is a tocolytic
Labor inducers:
o Prostaglandins and oxytocin both cause labor to start or proceed
o Oxytocin (Pitocin) is parenteral only (usually IV)
o PGE-2 does come in a gel that is applied to ripen the cervix prior to induction of labor & in suppositories
(still technically topical) to induce labor
Fetal alcohol syndrome: facial deformities (low nasal bridge, flat midface), postnatal growth retardation, or
mental retardation
Treatment of patent ductus arteriosus:
o *Indocin injection*
o Ibuprofen
o Oxygen
o Diuretics
o Purpose of the ductus arteriosus in utero: to shunt blood from the pulmonary artery to the aorta
Hydroxyurea (Droxia, Hydrea): use to increase fetal hemoglobin in sickle cell patients
Page 51
Causative agents: chlorpromazine, prazosin, trazodone, other phenothiazines, antihypertensives, anticoagulants,
corticosteroids, & any drug used to produce an erection
o PDE-5 inhibitors:
Sildenafil (Viagra)
Vardenafil (Levitra)
Tadalafil (Cialis)
• Can last up to 36 hours
Chronic, epidermal proliferative disease characterized by erythematous, dry scaling patches, recurring remissions
& exacerbations
o Mild to moderate disease:
Emollients BID: soft yellow paraffin or aqueous cream; petrolatum or Aquaphor cream (greasier
& more effective)
Topical, low potency corticosteroids on delicate skin (face, genitals): alclometasone
dipropionate, triamcinolone acetonide 0.025%, hydrocortisone 2.5%
Topical, medium potency cortisteroids: fluticasone propionate, triamcinolone acetonide 0.1%,
hydrocortisone valerate, mometasone furoate
Topical, strong potency: betamethasone dipropionate, halcinonide, fluocinonide, desoximetasone
Topical, super potency: augmented betamethasone dipropionate, diflorasone diacetate, clobetasol
propionate, halobetasol propionate
• Limit use to 2 weeks
• Avoid occlusive dressings
Intralesional corticosteroid: 2-5 mg/mL triamcinolone acetonide
Coal tar (Estar, PsoriGel) as an alterative to topical steroids
Keratolytic agents to decrease scales: salicyclic acid 6% gel
UV lamps & sunlight are effective- best option for pregnancy or young children
• Anthralin ointment 1% or higher prior to light
o Severe disease:
Triamcinolone, intralesional mix
Vitamin D analogs (calcipotriene ointment 0.05%- not on face)
Acitretin (Soriatane)
Tazarotene (Tazorac)
Methotrexate, hydroxyurea, azathioprine, or cyclosporine
o Triamcinolone (Aristocort A; Aristocort Forte; Aristospan; Azmacort; Kenalog; Nasacort AQ; Nasacort
HFA; Tri-Nasal; Triderm)
Psychriatric Disorders:
o Methylphenidate (Concerta, Methadate, Methylin, Ritalin)
MOA: reuptake blockade of catecholamine (NE & DA) in presynaptic nerve endings
Dosage form of Concerta: 18, 27, 36, 54 mg ER tablets
o Atomoxetine (Strattera):
BBW for suicide ideation in children
MOA: NE reuptake inhibitor
Dosed once daily (advantage over Concerta)
o SSRIs:
Citalopram (Celexa)
Escitalopram (Lexapro)
Fluvoxamine (Luvox)
Sertraline (Zoloft)
Fluoxetine (Prozac):
• Does not require tapering because of its long half life
Page 52
• Take in AM
Paroxetine (Paxil):
• Take in AM to reduce chances of insomnia
• Paxil CR incorporates a degradable polymeric matrix (Geomatrix) to control dissolution
rate over a period of 4-5 hours
o An EC delays the start of drug release until tablets have left the stomach
May take 4 weeks to see effects
Bupropion (Wellbutrin, Zyban):
• MOA: dopamine reuptake inhibitor
• CI with history of seizure disorder
Venlafaxine (Effexor):
• MOA: inhibits the reuptake of 5-HT & NE (& DA at higher doses)
• Referred to as a serotonin-norepinephrine reuptake inhibitor (SNRI)
• XR formulation is available to decrease GI upset
• Not recommended in patients with uncontrolled HTN, recent MI, or CV disorders
Duloxetine (Cymbalta):
• MOA: potent inhibitor of 5-HT & NE (no DA activity)
• Indicated for both major depression & diabetic peripheral neuropathic pain
• CI: uncontrolled narrow-angle glaucoma
Trazodone (Desyrel):
• MOA: inhibits 5-HT reuptake & blocks 5-HT2A receptors
Nefazodone (Serzone):
• MOA: inhibits 5-HT & NE uptake & blocks 5-HT2A receptors
Mirtazapine (Remeron):
• MOA: antagonizes presynaptic -2 autoreceptors & heteroreceptors that prevent the
release of 5-HT & NE (resulting in increased 5-HT & NE in the synapses); antagonizes
5-HT2A & 5-HT3 receptors, resulting in less GI upset & less anxiety
Olanzapine & fluoxetine (Symbax):
• Atypical antipsychotic agent/SSRI
• Use: treatment of depressive episodes associated with bipolar disorder
Isocarboxazid (Marplan)
Phenelzine (Nardil)
Tranylcypromine (Parnate)
Medications to avoid on MAOIs:
• Phenylpropanolamine: tyramine-like reaction
• Pseudoephedrine: tyramine-like reaction
• Meperidine (Demerol): life-threatening serotonin syndrome-like reaction
• Methyldopa (Aldomet): hypertensive crisis
• Morphine (Roxanol, MS Contin): CNS depression
• Reserpine (Ser-Ap-Es): increased catecholamines
• Serotonergic agents (i.e. fluoxetine): serotonin syndrome
MOA: increase the synaptic concentration of 5-HT &/or NE in the CNS by inhibiting the
presynaptic neuronal membrane’s reuptake of 5-HT or NE
Amitriptyline (Elavil)
• Off label use: neuropathic pain
Nortriptyline (Pamelor, Aventyl)
Imipramine (Tofranil)
Doxepin (Sinequan)
Clomipramine (Anafranil)
Desipramine (Norpramin)
Page 53
o Atypical:
Arpiprazole (Abilify):
• AE: insomnia, +/- weight gain
• Once daily dosing benefit
• Partial dopamine agonist
Clozapine (Clozaril, FazaClo-ODT:
• For refractory schizophrenia only
• AE: sedation, weight gain, hypersalivation, seizure risk
• Weekly CBC with diff required
o WBC <3500 or ANC <1500 MUST discontinue
Olanzapine (Zyprexa, Zydis-ODT):
• MOA: a thienobenzodiazepine antipsychotic that is believed to work by antagonizing
dopamine & serotonin activities
o It is a selective monoaminergic antagonist with high affinity binding to 5-HT2A &
5-HT2C, dopamine D1-4, muscarinic M1-5, histamine H1 & -1 receptor sites
o Binds weakly to GABA-A, BZD, & beta-adrenergic receptors
• AE: sedation, orthostasis
Quetiapine (Seroquel):
• Low EPS risk
Risperidone (Resperdal):
• Use: schizophrenia, bipolar
• Dosage forms: injection, solution, tablet, ODT
Ziprasidone (Geodon)
• AE: +/- sedation, +/- weight gain, QT prolongation
o Typical:
Chlorpromazine (Thorazine)
Fluphenzaine (Prolixin)
Haloperidol (Haldol)
Thioridazine (Mellaril)
• QT prolongation
Anxiolytic agents:
o Benzodiazepines:
MOA: potentiate the actions of GABA by increasing the influx of Cl ions into neurons
Alprazolam (Xanax, Niravam-ODT)
Chlordiazepoxide (Librium)
• Available as injection
Clonazepam (Klonopin)
• Available as an orally disintegrating wafer
Clorazepate (Tranxene)
Diazepam (Valium)
• Available as injection
Estazolam (Prosam)
Flurazepam (Dalmane)
Halazepam (Paxipam)
Lorazepam (Ativan)
• Available as an injection
Oxazepam (Serax)
Prazepam (Centrax)
Quazepam (Doral)
Temazepam (Restoril)
Trazolam (Halcion)
Lorazepam, oxazepam, & temazepam (LOT) are conjugated & preferred in patients with hepatic
dysfunction & elderly patients
Page 54
Chlordiazepoxide, diazepam, & lorazepam available for IV use
Never abruptly discontinue
Avoid in pregnancy- cause cleft palate
o Buspirone (BuSpar):
MOA: unknown. It exhibits high affinity for serotonin (5-HT1A) receptors, moderate affinity for
brain D2-dopamine receptors & no significant affinity for benzodiazepine receptors. It has no
effect on GABA binding.
Non-FDA labeled indication: depression
No grapefruit
Take consistently either with or without food
EPS treatment:
o Dystonia: state of abnormal tonicity, sometimes described simplistically as a severe “muscle spasm”
Benzotropine mesylate 2 mg
Diphenhydramine 50 mg IV or IM
Diazepam 5-10 mg by slow IV push
Lorazepam 1-2 mg IM
o Akathisia: inability to sit still & being functionally mortor restless
Diazepam 5 mg TID
Propanolol 10 mg QD
Nadolol 80 mg QD
• Beta 2 selective are less effective
o Pseudoparkinsonism: an AP-induced extrapyramidal side effect, resembles idiopathic Parkinson’s
Patient may have slurred speech & a drooping face
Trihexyphenidyl 2-5 mg TID
Diphenhydramine 25-50 mg TID
Biperiden (Akineton) 2 mg TID
o Tardive dyskinesia: syndrome characterized by abnormal involuntary movements occurring late in onset
in relation to initiation or AP therapy
No FDA approved agents
-tocopherol (vitamin E) 1200-1600 IU has been tried
Lithium (Eskalith CR, Lithobid, Eskalith):
o Use: bipolar disorder
o CI: renal disease, severe CVD, pregnancy
o SE: hyponatremia
o Monitor thyroid function
o “Lithium does everything that sodium will do”
o Reaches steady state in 4-5 days
Obtain level 2-8 hours post-dose
• Mild (serum levels 1.5-2):
o GI upset (N/V/D), muscle weakness, fatigue, fine hand tremor, difficulty with
concentration & memory
• Moderate (2-2.5):
o Ataxia, lethargy, nystagmus, worsening confusion, severe GI upset, coarse
tremors, increased deep tendon reflexes
• Severe (>3):
o Severely impaired consciousness, coma, seizures, respiratory complications,
o Dosage forms: capsules, syrup, tablet (IR, CR, slow release)
Tourette’s Syndrome:
o Simple tics & 1st line of therapy is short acting benzodiazepines
o Next is clonidine which does not cause tardive dyskinesia in these patients
Page 55
Intermediate acting benzodiazepines (Ativan) are also useful
For severe cases, the choice is an antipsychotic such as haloperidol (Haldol) or pimozide (Orap) but these
can cause tardive dyskinesia, dysphoria, & pseudoparkinson’s
Anon-sedating anxiolytic for the elderly: buspirone (Buspar)
o Has a high affinity for 5-HT & dopamine receptors
o Does not affect benzodiazepine GABA receptors
Mother has gestational diabetes, what is likely to occur when the baby is born. Mother also has epilepsy & is
taking tegretol.
o I. high birth weight
o II. Baby may have congenital abnormalities
o III. Baby is likely to have diabetes
o Answer: I & II
o Tegretol is a class D drug
What strength will Albuterol 0.5% end up based on an order to mix it with 2.5 mL normal saline?
o 0.083%
Isosorbide dinitrate is dosed BID, what regimen is best 7 am & 12 noon, 7 am & 7 pm, 9 am & 9 pm, 8 am & 5
o 8 am & 5 pm to allow nitrate free period (same as removing NTG patches at bedtime)
What substitute can you use for desitin ointment (Balmex, Boudreaux’s Butt Paste)?
o Zinc oxide
Precose counseling information:
o I. Take 30 minutes before meal
o II. Causes gas
o III. Should not take if meal skipped
o Answer: II & III
What treatment would increase antibiotic compliance? Patient receiving zithromax 1 tsp QD x 5days
o Augment, ceftriaxone, cefuroxime axetil, doxycycline
o Answer: the usual method to improve compliance for any type of drug is to reduce the number of doses
that must be taken each day & to give a drug with the fewest uncomfortable or dangerous SE (I would
chose ceftriaxone- IM single dose treatment)
Which of the following could you give a patient on NTG?
o I. Cialis
o II. Muse (alprostadil)
o III. Caverject (alprostadil)
o Answer: II & III- alprostadil is prostaglandin used for erectile dysfunction & patent ductus arteriosus
Available as: intracavernosal Kit, intracavernosal powder for solution, intracavernosal solution,
intraurethral Suppository, & intraurethral solution
Patient requesting antihistamine eye drop & having a dark spot in vision- refer to MD
Which of the following is available in a liquid formulation?
o I. NTG
o II. Hydroxyzine
o III. Digoxin
o Answer: II & III
Which is the shortest acting insulin?
o Humulin N, Humulin U, Humalog, or regular
o Answer: Humalog
Who should not get a flu shot?
o An infant in day care; 32 yo type II diabetic; 65 yo retired lady; 35 yo nurse working in hospital
Answer: 32 yo type II diabetic
Which of the following cannot be self monitored?
o Glucose level; K level; cholesterol levels; hormone used in pregnancy test
o Answer: K levels
Cytoxan is most similar to mechlorethamine, procarbazine, or 5-FU?
Page 56
o Answer: mechlorethamine
A patient with Traveler’s diarrhea too PeptoBismol 4 tsp Q ½ hour. After 3 days he began experiencing ringing
in the ears. What does he have? Bismuth toxicity or salicylate toxicity?
o Answer: salicylate toxicity
o Bismuth toxicity would cause neurotoxicity
Which of the following are OTC hemorrhoid treatments:
o I. TUCKs pads
o II. Nupercainal ointment
o III. Rowasa
o Answer: I & II
Which of the following is an ER Morphine?
B. MS Contin
C. Diluadid
D. Oxycontin
o Answer: B
Which of the following agents should be administered to a person exposed to Anthrax?
o A. Flagyl
B. Cipro
C. Zovirax
D. Valtrex
o Answer: B
Erythromycin exhibits its anti-infective properties by- blocking protein synthesis via binding & inhibition of the
50-S subunit of bacterial ribosomes
Patient has pseudomembranous colitis & allergy to metronidazole. Which of the patient’s medications could have
caused the pseudomembrane colitis?
o A. Ibuprofen B. Tylenol
C. Flagyl
D. Cleocin
E. Zantac
o Answer: D
o This person could be treated with?
A. Flagyl
B. VancomycinC. Doxycycline D. Lincomycin E. Ampicillin
Answer: B
o The DOC for the treatment of pseudomembraneous colitis is:
A. Metronidazole
B. Erythromycin C. Clindamycin
D. Ampicillin E.
Answer: A
Which of the following NSAIDs has an ophthalmic preparation:
o A. Ibuprofen B. Naproxen C. Diclofenac D. Ketoprofen
o Answer: C- Voltaren
Cedax acts by- inhibiting the use of pencillin binding proteins in bacterial cell wall synthesis
Acetylcysteine in the treatment of CF is best given:
o A. IV
B. By inhalation
D. Orally
o Answer: B
A patient is given a rx for fentanyl 100 mcg/hr patch for 1 month. How many boxes should you dispense?
o A. 1 B. 2 C. 3 D. 4 E. 5
o Answer: 2; 1 patch= 3 days, so you need 10 patches; comes in boxes of 5 patches so you need 2
Which of the following is not an erythropoetin formulation?
o A. Epogen
B. Procrit
C. Aranesp
D. Neupogen
o Answer: Neupogen
Which of the following fluoroquinolones has an otic preparation?
o Answer: ofloxacin (Floxin- also has an ophthalmic);
o Eye drops only: levofloxacin, gatifloxacin, moxifloxacin
The use of this agent is CI in children?
o A. Erythromycin
B. Bactrim
C. Ciprofloxacin
D. Cephalexin
o Answer: C
What is the recommended daily dosage of calcium for an adult?
o A. 300-500 mg B. 600-800 mg C. 800-1000 mg
D. 100-1500 mg
o Answer: D
Due to difficulty in coordinating their inhalations, older patients should use:
o A. Nebulizer B. Peak flow meter
C. Spacers
D. Spirometer
o Answer: C
Monitoring of asthma at home can be done with:
Page 57
o A. Nebulizer B. Peak flow meter
C. Spacers
o Answer: B
A patient using a One-Touch machine will also need:
o A. Ketostix
B. Cuff
C. Lancing device
o Answer: C
D. Spirometer
D. Sphygmomanometer
Raynaud’s Phenomenon:
Reversible vasospasm of the digital arteries that can result in ischemia of the digits
Avoid exposure to cold
CCB’s (i.e. nifedipine) are the preferred initial agents
Alternative vasodilators, such as prazosin (Minipress), may be helpful
Aggregated by beta blockers
Drotrecogin alpha (Xigris):
o Recombinant human activated protein C
o Has antithrombic, anti-inflammatory, & profibrinolytic properties
o Dosed 24 mcg/kg body weight/hr
o CI: increased risk of hemorrhage
o MOA: inhibits factors Va & VIIIa, limiting thrombotic effects
A form of pneumoconiosis resulting from occupational exposure to & inhalation of silica dust over a period of
Characterized by a slowly progressive fibrosis of the lungs, which may result in impairment of lung function
Predisposes person to pulmonary tuberculosis
Mean: the average of a set of values
Median: the middle value in a set of measurement
Mode: the value that appears most frequently
Statistically significant: the likelihood (probability) of obtaining a given result by chance
o p < 0.05
Standard deviation: statistical index of the degree of deviation from central tendency, namely, of the variability
within a distribution
T Test: used to compare two groups
Blood glucose kits:
o Testing without pricking finger: Clinitest Tabs & TesTap- used to test urine sugar then correlate to blood
Cholesterol Kits
o Advanced cholesterol test kit
Need to avoid for at least 4 hours prior to testing: iron, prozac, vitamin c, APAP
Heme guaiac exam:
o Vitamin C (antioxidant) can interfere with test
o Visual limitations can limit test
o Hemorrhoids (blood would cause a false +)
o Example test: EZ detector
Patient with a high PTT & receiving heparin:
o Could hold it then restart it at a lower dose
Patient on lovenox & warfarin:
o Appropriate to monitor:
APTT (no)
Page 58
PT (yes for warfarin)
INR (yes for warfarin)
Ovulation tests:
o Test a rise in leutinizing hormone (LH) as an indicator for ovulation
o Examples include: First Response, Ovutime, Q-Test
Pregnancy tests:
o Measure a rise in the level of chorionic gonadotropin (HCG, CG) that begins the 2nd week of pregnancy &
peeks at about 8 weeks
Detect contraception 2 weeks after last missed period
Take first thing in the AM
Taking BP:
o Patients should refrain from smoking or caffeine ingestion for 30 min
o Measurement should begin after being seating at least 5-min
o Proper size cuff should be used
The bladder should encircle at least 80% of the arm & the width of the cuff should be at least 2/3
the length of the upper arm
o Position cuff 1 inch above antecubital crease
o Ask patient about previous readings
o Inflate cuff rapidly to approximately 30 mm Hg above previous readings
o Deflate slowly & listen for Korotkoff sounds
o Wait 1-2 minutes before repeating
o Fluctuation of BP by 10 mm Hg from morning to night is normal
Urine glucose test kits:
o Clinitest tabs
Test method: copper sulfate
Urine & water mix in test tube, add reduction method tablet, wait for reaction end, see resulting
color on chart
o Chemstrip-uG
Test method: glucose oxidase
Dip stick into urine and wait for color to develop, then read on chart
o Clinistix, Diastix, TesTape
Test method: glucose oxidase
Dip stick in urine read color change on chart; dextrose only
o The copper sulfate method is better quantitatively but is subject to more interferences (false +)
o The glucose oxidase method is less subject to interferences but is less accurate
Active immunity: protection produced by an individual’s own immune system
o Vaccination: process of producing active immunity via use of vaccines
Passive immunity: protection produced by an animal or human & transferred to another
o Ex: immunity infants receive from mother
o One source of passive immunity is antitoxins, which contain antibodies against a known toxin
Live vaccines:
o Influenza (live-attenuated), measles, mumps, rubella, typhoid oral, *varicella*, vaccinia (small pox),
yellow fever
Avoid with AIDS
Inactivated vaccines: anthrax, diphtheria, H. flu type b, hepatitis A & B, influenza, Japanese encephalitis,
meningococcal, pertassis (acellular), pneumococcal (polysaccharide & conjugate), rabies, tetanus, typhoid
Vaccine ok for pregnancy: flu (2nd or 3rd trimester) & tetanus
o AVOID MMR for the rubella part & varicella
o AVOID live viruses
o Do not give till 2nd trimester
o Hepatitis B, inactivated polio, & pneumococcal are all recommended if indicated
Vaccine needed in asthma patients: influenza
Page 59
Vaccines that come PO & IV:
o Polio
IPOL: inactivated, trivalent injectable vaccine
OPV: oral- discontinued in US because of elimination of wild-type disease
Prevnar: vaccine against a collection of bacteria that cause pneumonia
o Used in children up to 5 years old & usually delayed until child is 2
Patients with spleenectomy:
o Pneumococcal vaccine is most essential
o Can also give: Hep A & B, MMR, varicella, flu
Vaccines grown in eggs: influenza (CI), measles (“should receive it”), mumps (not a CI)
Vaccines that can be given around 2 months of age: hepB, DTaP (diphtheria, tetanus, pertussis), Hib
(haemophilus influenza type b), IPV (polio), PCV (pneumococcal)
Diphtheria & tetanus: give Q 10 years
Elemental calcium:
o Calcium carbonate: 40%
Tums contains 500 mg of calcium carbonate, therefore 200 mg of element calcium is provided
o Calcium phosphate tribasic: 39%
o Calcium citrate: 24%
Elemental Iron:
o Ferrous fumarate (Femiron, Fumerin, Feostat): 33%
o Ferrous sulfate (Feosol, Fer-in-Sol): 20%
o Ferrous gluconate (Fergon): 12%
Weight Loss:
Noradrenergic Agents:
o Methamphetamine
o Amphetamine
o Dextroamphetamine (Dexedrine)
o Benzphetamine (Didrex)
o Amphetamine/dextroamphetamine mixture (Adderall)
o Phendimetrazine (Prelu-2, Bontril, Plegine, X-Trazine)
o Phentermine (Fastin, Oby-trim, Adipex-P, Ionamin)
o Diethylpropion (Tenuate)
o Mazindol (Mazanor, Sanorex)
Serotonergic Agents:
o Fluoxetine (Prozac) & Sertraline (Zoloft)- unlabeled uses
Noradrenergic/Serotonergic Agents:
o Sibutramine (Meridia)
Strength: 5, 10 & 15 mg capsules
Gastrointestinal Lipase Inhibitor:
o Orlistat (Xenical)
Oily spotting; fecal incontinence
Absorption of fat soluble vitamins may be decreased
Strength: 120 mg capsule
Wilson’s Disease:
An autosomal recessive disorder that results in progressive copper overload
The average age at presentation of liver dysfunction is 10-15 years
Neuropsychiatric disorders can manifest later
o Copper-chelating agents:
Penicillamine (Cuprimine, Depen)
Page 60
MOA: chelates with lead, copper, mercury, & other heavy metals to form stable, soluble
complexes that are excreted in urine
Trientine (Syprine):
• MOA: an oral chelating agent structurally dissimilar from penicillamine & other
available chelating agents
Zinc salts
Women’s Health:
Birth Control:
o Sunday start for BC pills means: start the pack on the Sunday after the period starts
o Estrogen:’
Prevent development of a dominant follicle by suppression of FSH; does not block ovulation
• SE: breast tenderness, heavy bleeding, headache
o Progestin:
Blocks ovulation; contributes to production of thick & impermeable cervical mucus; contributes
to involution & atrophy of endometrium
• SE: depression, headache, irritability
o Progesterone: decreases the risk of endometrial cancer
o Progestin-only (minipill):
Appropriate for use in breastfeeding women
Efficacy is less than that of combined oral contraceptives
Free of cardiovascular risks associated with estrogen-containing products
Ortho Micronor, Errin, Nor-QD, Nora-BE, Camila, Ovrette
o Biphasic oral contraceptives: Ortho-Novum 10/11, Necon 10/11
o Yasmin:
Ethinyl estradiol & drospirenone
• Drospirenone is a spironolactone analogue with antimineralocorticoid & antiandrogenic
o Symptoms: depressed mood, mood swings, irritability, difficulty concentrating, fatigue, edema, breast
tenderness, headaches, sleep disturbances
Postmenopausal hormone replacement therapy:
o Women with an intact uterus must be treated with estrogen + progestin
o Women with out a uterus- estrogen only
o Ingredients in PremPro or Premphase: conjugated estrogen & medroxyprogesterone
Levonorgestrel (Plan B, Mirena-intrauterine system):
o For emergency contraception: 1 tablet (0.75 mg) asap within 72 hours of unprotected sexual intercourse;
a 2nd tablet (0.75 mg) should be taken 12 hours after the 1st dose; can be used at any time during the
menstrual cycle
Zollinger-Ellison Syndrome:
A triad of:
o Markedly elevate gastric acid secretion
o Peptic ulcer disease
o A gastrinoma or non-beta islet cell tumor of the pancreas or duodenal wall which produces gastrin
o PPIs:
Omeprazole 60-120 mg/day
Lansoprazole 60-180 mg/day
Rabeprazole 60-100 mg/day
Pantoprazole 40-240 mg/day
o H2 blockers:
Cimetidine 300 mg Q6h; up to 1.25-5 gm/day
Ranitidine 150 mg Q12h; up to 6 gm/day
Famotidine 20 mg at bedtime; up to 800 mg QD
Page 61

Report this document